Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Osteoporosis

  Free Subscription


Articles published in Osteoporos Int

Retrieve available abstracts of 584 articles:
HTML format
Text format



Single Articles


    August 2019
  1. LE B, Ray C, Gonzalez B, Miskevics S, et al
    Laboratory evaluation of secondary causes of bone loss in Veterans with spinal cord injury and disorders.
    Osteoporos Int. 2019 Aug 13. pii: 10.1007/s00198-019-05089.
    PubMed     Text format     Abstract available


  2. SUGIMOTO T, Shiraki M, Fukunaga M, Kishimoto H, et al
    Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study.
    Osteoporos Int. 2019 Aug 8. pii: 10.1007/s00198-019-05111.
    PubMed     Text format     Abstract available


  3. HILIGSMANN M, Cornelissen D, Vrijens B, Abrahamsen B, et al
    Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskel
    Osteoporos Int. 2019 Aug 7. pii: 10.1007/s00198-019-05104.
    PubMed     Text format     Abstract available


  4. LOU S, Shi X, Zhang X, Lyu H, et al
    Percutaneous vertebroplasty versus non-operative treatment for osteoporotic vertebral compression fractures: a meta-analysis of randomized controlled trials.
    Osteoporos Int. 2019 Aug 3. pii: 10.1007/s00198-019-05101.
    PubMed     Text format     Abstract available


  5. HARRIS AM, Lee AR, Wong SC
    Systematic review of the effects of bisphosphonates on bone density and fracture incidence in childhood acute lymphoblastic leukaemia.
    Osteoporos Int. 2019 Aug 3. pii: 10.1007/s00198-019-05082.
    PubMed     Text format     Abstract available


  6. HEIDARI ME
    Letter to the Editor about the article "A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk".
    Osteoporos Int. 2019 Aug 2. pii: 10.1007/s00198-019-05113.
    PubMed     Text format    


  7. LU JX, Pan H, Hu XQ, Huang ZW, et al
    Effects of milk powder intervention on bone mineral density and indicators related to bone metabolism in Chinese adolescents.
    Osteoporos Int. 2019 Aug 2. pii: 10.1007/s00198-019-05105.
    PubMed     Text format     Abstract available


  8. KHASHAYAR P, Keshtkar A, Ostovar A, Larijani B, et al
    FRAX-based intervention and assessment thresholds for osteoporosis in Iran.
    Osteoporos Int. 2019 Aug 1. pii: 10.1007/s00198-019-05078.
    PubMed     Text format     Abstract available


    July 2019
  9. BERGMAN J, Nordstrom A, Hommel A, Kivipelto M, et al
    Bisphosphonates and mortality: confounding in observational studies?
    Osteoporos Int. 2019 Jul 31. pii: 10.1007/s00198-019-05097.
    PubMed     Text format     Abstract available


  10. HOLLOWAY-KEW KL, Marijanovic N, De Abreu LLF, Sajjad MA, et al
    Bone mineral density in diabetes and impaired fasting glucose.
    Osteoporos Int. 2019 Jul 31. pii: 10.1007/s00198-019-05108.
    PubMed     Text format     Abstract available


  11. NORDSTROM P, Nordstrom A
    Use of short-acting and long-acting hypnotics and the risk of fracture: a critical analysis of associations in a nationwide cohort.
    Osteoporos Int. 2019 Jul 30. pii: 10.1007/s00198-019-05085.
    PubMed     Text format     Abstract available


  12. HOLLOWAY-KEW KL, Zhang Y, Betson AG, Anderson KB, et al
    How well do the FRAX (Australia) and Garvan calculators predict incident fractures? Data from the Geelong Osteoporosis Study.
    Osteoporos Int. 2019 Jul 18. pii: 10.1007/s00198-019-05088.
    PubMed     Text format     Abstract available


  13. HAYES KN, Ban JK, Athanasiadis G, Burden AM, et al
    Time trends in oral bisphosphonate initiation in Ontario, Canada over 20 years reflect drug policy and healthcare delivery changes.
    Osteoporos Int. 2019 Jul 17. pii: 10.1007/s00198-019-05061.
    PubMed     Text format     Abstract available


  14. KANTEREWICZ E, Puigoriol E, Rodriguez Cros JR, Peris P, et al
    Correction to: Prevalent vertebral fractures and minor vertebral deformities analyzed by vertebral fracture assessment (VFA) increases the risk of incident fractures in postmenopausal women: the FRODOS study.
    Osteoporos Int. 2019 Jul 17. pii: 10.1007/s00198-019-05050.
    PubMed     Text format     Abstract available


  15. VRANKEN L, Wyers CE, van Rietbergen B, Driessen JHM, et al
    The association between prevalent vertebral fractures and bone quality of the distal radius and distal tibia as measured with HR-pQCT in postmenopausal women with a recent non-vertebral fracture at the Fracture Liaison Service.
    Osteoporos Int. 2019 Jul 17. pii: 10.1007/s00198-019-05081.
    PubMed     Text format     Abstract available


  16. JEPSEN DB, Ryg J, Hansen S, Jorgensen NR, et al
    The combined effect of Parathyroid hormone (1-34) and whole-body Vibration exercise in the treatment of postmenopausal OSteoporosis (PaVOS study): a randomized controlled trial.
    Osteoporos Int. 2019 Jul 15. pii: 10.1007/s00198-019-05029.
    PubMed     Text format     Abstract available


  17. FUZZELL LN, Richards MJ, Fraenkel L, Stark SL, et al
    What information can the lay public find about osteoporosis treatment? A descriptive study coding the content and quality of bisphosphonate information on the internet.
    Osteoporos Int. 2019 Jul 11. pii: 10.1007/s00198-019-05008.
    PubMed     Text format     Abstract available


  18. PFLIMLIN A, Gournay A, Delabriere I, Chantelot C, et al
    Correction to: Secondary prevention of osteoporotic fractures: evaluation of the Lille University Hospital's Fracture Liaison Service between January 2016 and January 2018.
    Osteoporos Int. 2019 Jul 8. pii: 10.1007/s00198-019-05075.
    PubMed     Text format     Abstract available


  19. SVEDBOM A, Hadji P, Hernlund E, Thoren R, et al
    Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom.
    Osteoporos Int. 2019 Jul 3. pii: 10.1007/s00198-019-05064.
    PubMed     Text format     Abstract available



  20. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Author index.
    Osteoporos Int. 2019;30.
    PubMed     Text format    



  21. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Satellite Symposia Abstracts.
    Osteoporos Int. 2019;30.
    PubMed     Text format    



  22. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Posters Abstracts.
    Osteoporos Int. 2019;30.
    PubMed     Text format    



  23. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Non-Sponsored Symposia Abstracts.
    Osteoporos Int. 2019;30.
    PubMed     Text format    



  24. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Meet-the-Experts Abstracts.
    Osteoporos Int. 2019;30.
    PubMed     Text format    



  25. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): ESCEO-IOF-SFR-GRIO Symposium Abstracts.
    Osteoporos Int. 2019;30.
    PubMed     Text format    



  26. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): ESPRM-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2019;30.
    PubMed     Text format    



  27. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): EUGMS-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2019;30.
    PubMed     Text format    



  28. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): ESCEO-IOF USA Symposium Abstracts.
    Osteoporos Int. 2019;30.
    PubMed     Text format    



  29. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): ESCEO-IOF-WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging Symposium Abstracts (ESCEO-IOF-WHO CC).
    Osteoporos Int. 2019;30.
    PubMed     Text format    



  30. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): ESCEO-WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Ageing Symposium Abstracts (ESCEO-WHO CC).
    Osteoporos Int. 2019;30.
    PubMed     Text format    



  31. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): ESCEO Symposia Abstracts.
    Osteoporos Int. 2019;30.
    PubMed     Text format    



  32. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Oral Communications Abstracts.
    Osteoporos Int. 2019;30.
    PubMed     Text format    



  33. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Plenary Lectures Abstracts.
    Osteoporos Int. 2019;30.
    PubMed     Text format    



  34. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Special Lectures Abstracts.
    Osteoporos Int. 2019;30.
    PubMed     Text format    



  35. WORLD CONGRESS ON OSTEOPOROSIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES.
    Osteoporos Int. 2019;30.
    PubMed     Text format    


    June 2019
  36. KRISTENSEN PK, Ehrenstein V, Shetty N, Pedersen AB, et al
    Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better?
    Osteoporos Int. 2019 Jun 29. pii: 10.1007/s00198-019-05066.
    PubMed     Text format     Abstract available


  37. HAGINO H, Narita R, Yokoyama Y, Watanabe M, et al
    A multicenter, randomized, rater-blinded, parallel-group, phase 3 study to compare the efficacy, safety, and immunogenicity of biosimilar RGB-10 and reference once-daily teriparatide in patients with osteoporosis.
    Osteoporos Int. 2019 Jun 26. pii: 10.1007/s00198-019-05038.
    PubMed     Text format     Abstract available


  38. JOHANSSON L, Svensson HK, Karlsson J, Olsson LE, et al
    Decreased physical health-related quality of life-a persisting state for older women with clinical vertebral fracture.
    Osteoporos Int. 2019 Jun 21. pii: 10.1007/s00198-019-05044.
    PubMed     Text format     Abstract available


  39. GE G, Li J, Wang Q
    Heart failure and fracture risk: a meta-analysis.
    Osteoporos Int. 2019 Jun 19. pii: 10.1007/s00198-019-05042.
    PubMed     Text format     Abstract available


  40. LIU C, Wang L, Zhu R, Liu H, et al
    Correction to: Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/beta-catenin signaling pathway in OVX rats.
    Osteoporos Int. 2019 Jun 18. pii: 10.1007/s00198-019-05028.
    PubMed     Text format     Abstract available


  41. CARBONE LD, Vasan S, Prentice RL, Harshfield G, et al
    The renin-angiotensin aldosterone system and osteoporosis: findings from the Women's Health Initiative.
    Osteoporos Int. 2019 Jun 17. pii: 10.1007/s00198-019-05041.
    PubMed     Text format     Abstract available


  42. ASGHAR ZB, Godoy Caballero A, Pathirannehelage S, Williams J, et al
    Saving bones without risking brain-bisphosphonates and risk of stroke: matched case-control study.
    Osteoporos Int. 2019 Jun 17. pii: 10.1007/s00198-019-05045.
    PubMed     Text format     Abstract available


  43. BILEZIKIAN JP, Lin CJF, Brown JP, Wang AT, et al
    Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.
    Osteoporos Int. 2019 Jun 14. pii: 10.1007/s00198-019-05020.
    PubMed     Text format     Abstract available


  44. DENNISON EM, Cooper C, Kanis JA, Bruyere O, et al
    Fracture risk following intermission of osteoporosis therapy.
    Osteoporos Int. 2019 Jun 7. pii: 10.1007/s00198-019-05002.
    PubMed     Text format     Abstract available


  45. PFIMLIN A, Gournay A, Delabriere I, Chantelot C, et al
    Secondary prevention of osteoporotic fractures: evaluation of the Lille University Hospital's Fracture Liaison Service between January 2016 and January 2018.
    Osteoporos Int. 2019 Jun 5. pii: 10.1007/s00198-019-05036.
    PubMed     Text format     Abstract available


  46. VAN DORT MJ, Driessen JHM, Geusens P, Romme EAPM, et al
    Vertebral bone attenuation in Hounsfield Units and prevalent vertebral fractures are associated with the short-term risk of vertebral fractures in current and ex-smokers with and without COPD: a 3-year chest CT follow-up study.
    Osteoporos Int. 2019 Jun 3. pii: 10.1007/s00198-019-04977.
    PubMed     Text format     Abstract available


    May 2019
  47. NOE S, Jaeger H, Wolf E
    Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis : Comment on "Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporos
    Osteoporos Int. 2019 May 29. pii: 10.1007/s00198-019-05024.
    PubMed     Text format    


  48. BIVER E, Calmy A, Meier C
    Reply to "Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against O
    Osteoporos Int. 2019 May 29. pii: 10.1007/s00198-019-05025.
    PubMed     Text format    


  49. SWANSON CM, Blatchford PJ, Orwoll ES, Cauley JA, et al
    Association between objective sleep duration and bone mineral density in older postmenopausal women from the Study of Osteoporotic Fractures (SOF).
    Osteoporos Int. 2019 May 28. pii: 10.1007/s00198-019-05007.
    PubMed     Text format     Abstract available


  50. HIDAYAT K, Du X, Shi BM
    Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in real-world use: systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2019 May 27. pii: 10.1007/s00198-019-04968.
    PubMed     Text format     Abstract available


  51. HONG WJ, Chen W, Yeo KJ, Huang PH, et al
    Increased risk of osteoporotic vertebral fracture in rheumatoid arthritis patients with new-onset cardiovascular diseases: a retrospective nationwide cohort study in Taiwan.
    Osteoporos Int. 2019 May 24. pii: 10.1007/s00198-019-04966.
    PubMed     Text format     Abstract available


  52. KANTEREWICZ E, Puigoriol E, Rodriguez Cros JR, Peris P, et al
    Prevalent vertebral fractures and minor vertebral deformities analyzed by vertebral fracture assessment (VFA) increases the risk of incident fractures in postmenopausal women: the FRODOS study.
    Osteoporos Int. 2019 May 23. pii: 10.1007/s00198-019-04962.
    PubMed     Text format     Abstract available


  53. HYGUM K, Harslof T, Langdahl B, Starup-Linde J, et al
    Glucagon-like peptide-1 receptor agonists and fracture risk-limitations to current knowledge.
    Osteoporos Int. 2019 May 22. pii: 10.1007/s00198-019-05013.
    PubMed     Text format    


  54. ZHOU W, Liu Y, Guo X, Yang H, et al
    Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis.
    Osteoporos Int. 2019 May 21. pii: 10.1007/s00198-019-05005.
    PubMed     Text format     Abstract available



  55. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Committee of National Societies Abstracts.
    Osteoporos Int. 2019 May 17. pii: 10.1007/s00198-019-04981.
    PubMed     Text format    


  56. MOTT A, Bradley T, Wright K, Cockayne ES, et al
    Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials.
    Osteoporos Int. 2019 May 10. pii: 10.1007/s00198-019-04949.
    PubMed     Text format     Abstract available


  57. HOPMAN WM, Berger C, Joseph L, Morin SN, et al
    Longitudinal assessment of health-related quality of life in osteoporosis: data from the population-based Canadian Multicentre Osteoporosis Study.
    Osteoporos Int. 2019 May 8. pii: 10.1007/s00198-019-05000.
    PubMed     Text format     Abstract available


  58. CHANDLER H, Brooks DJ, Hattersley G, Bouxsein ML, et al
    Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia.
    Osteoporos Int. 2019 May 3. pii: 10.1007/s00198-019-04999.
    PubMed     Text format     Abstract available


  59. RUPP T, Butscheidt S, Vettorazzi E, Oheim R, et al
    High FGF23 levels are associated with impaired trabecular bone microarchitecture in patients with osteoporosis.
    Osteoporos Int. 2019 May 1. pii: 10.1007/s00198-019-04996.
    PubMed     Text format     Abstract available


  60. CHEN WC, Lin EY, Kang YN
    Efficacy and safety of elcatonin in postmenopausal women with osteoporosis: a systematic review with network meta-analysis of randomized clinical trials.
    Osteoporos Int. 2019 May 1. pii: 10.1007/s00198-019-04997.
    PubMed     Text format     Abstract available


    April 2019
  61. MINNS LOWE CJ, Toye F, Barker KL
    Men's experiences of having osteoporosis vertebral fractures: a qualitative study using interpretative phenomenological analyses.
    Osteoporos Int. 2019 Apr 30. pii: 10.1007/s00198-019-04973.
    PubMed     Text format     Abstract available


  62. JEON CH, Chung NS, Lee HD, Won SH, et al
    Case report: electrical automated massage chair use can induce osteoporotic vertebral compression fracture.
    Osteoporos Int. 2019 Apr 23. pii: 10.1007/s00198-019-04961.
    PubMed     Text format     Abstract available


  63. LESLIE WD, Martineau P, Bryanton M, Lix LM, et al
    Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
    Osteoporos Int. 2019 Apr 23. pii: 10.1007/s00198-019-04975.
    PubMed     Text format     Abstract available


  64. BOREK DM, Smith RC, Gruber CN, Gruber BL, et al
    Long-term persistence in patients with osteoporosis receiving denosumab in routine practice: 36-month non-interventional, observational study.
    Osteoporos Int. 2019 Apr 22. pii: 10.1007/s00198-019-04963.
    PubMed     Text format     Abstract available


  65. TAMIMI I, Nicolau B, Eimar H, Arekunnath Madathil S, et al
    Correction to: Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study.
    Osteoporos Int. 2019 Apr 15. pii: 10.1007/s00198-019-04950.
    PubMed     Text format     Abstract available


  66. MA M, Huang DG, Liang X, Zhang L, et al
    Integrating transcriptome-wide association study and mRNA expression profiling identifies novel genes associated with bone mineral density.
    Osteoporos Int. 2019 Apr 15. pii: 10.1007/s00198-019-04958.
    PubMed     Text format     Abstract available


  67. ZHANG J, Zhang T, Xu X, Cai Q, et al
    Zoledronic acid combined with percutaneous kyphoplasty in the treatment of osteoporotic compression fracture in a single T12 or L1 vertebral body in postmenopausal women.
    Osteoporos Int. 2019 Apr 11. pii: 10.1007/s00198-019-04896.
    PubMed     Text format     Abstract available


  68. REGINSTER J-, Bianic F, Campbell R, Martin M, et al
    Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis.
    Osteoporos Int. 2019 Apr 6. pii: 10.1007/s00198-019-04947.
    PubMed     Text format     Abstract available


  69. ROH YH, Lee ES, Ahn J, Kim HS, et al
    Factors affecting willingness to get assessed and treated for osteoporosis.
    Osteoporos Int. 2019 Apr 3. pii: 10.1007/s00198-019-04952.
    PubMed     Text format     Abstract available


    March 2019
  70. SALARI-MOGHADDAM A, Sadeghi O, Keshteli AH, Larijani B, et al
    Metformin use and risk of fracture: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2019 Mar 29. pii: 10.1007/s00198-019-04948.
    PubMed     Text format     Abstract available


  71. WATTS NB, Hattersley G, Fitzpatrick LA, Wang Y, et al
    Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.
    Osteoporos Int. 2019 Mar 21. pii: 10.1007/s00198-019-04890.
    PubMed     Text format     Abstract available



  72. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - Author Index.
    Osteoporos Int. 2019 Mar 21. pii: 10.1007/s00198-019-04915.
    PubMed     Text format    


  73. BULLEN AL, Anderson CAM, Hooker ER, Kado DM, et al
    Correlates of T50 and relationships with bone mineral density in community-living older men: the osteoporotic fractures in men (MrOS) study.
    Osteoporos Int. 2019 Mar 18. pii: 10.1007/s00198-019-04925.
    PubMed     Text format     Abstract available


  74. PERRIER-CORNET J, Omorou AY, Fauny M, Loeuille D, et al
    Opportunistic screening for osteoporosis using thoraco-abdomino-pelvic CT-scan assessing the vertebral density in rheumatoid arthritis patients.
    Osteoporos Int. 2019 Mar 13. pii: 10.1007/s00198-019-04931.
    PubMed     Text format     Abstract available


  75. SALE JEM, Marwah A, Naeem F, Yu W, et al
    Evidence of patient beliefs, values, and preferences is not provided in osteoporosis clinical practice guidelines.
    Osteoporos Int. 2019 Mar 11. pii: 10.1007/s00198-019-04913.
    PubMed     Text format     Abstract available


  76. DEGBOE Y, Eischen M, Apoil PA, Mailhol C, et al
    Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome.
    Osteoporos Int. 2019 Mar 7. pii: 10.1007/s00198-019-04918.
    PubMed     Text format     Abstract available


  77. EL HAGE C, Hallit S, Akel M, Dagher E, et al
    Osteoporosis awareness and health beliefs among Lebanese women aged 40 years and above.
    Osteoporos Int. 2019 Mar 6. pii: 10.1007/s00198-019-04901.
    PubMed     Text format     Abstract available


  78. WU DY, Qiao D, Zhang X, Zhang HQ, et al
    Lipid profiles as potential mediators linking body mass index to osteoporosis among Chinese adults: the Henan Rural Cohort Study.
    Osteoporos Int. 2019 Mar 5. pii: 10.1007/s00198-019-04878.
    PubMed     Text format     Abstract available


  79. VALENTINITSCH A, Trebeschi S, Kaesmacher J, Lorenz C, et al
    Opportunistic osteoporosis screening in multi-detector CT images via local classification of textures.
    Osteoporos Int. 2019 Mar 4. pii: 10.1007/s00198-019-04910.
    PubMed     Text format     Abstract available


    February 2019
  80. SPECHBACH H, Fabreguet I, Saule E, Hars M, et al
    Higher rates of osteoporosis treatment initiation and persistence in patients with newly diagnosed vertebral fracture when introduced in inpatients than later in outpatients.
    Osteoporos Int. 2019 Feb 28. pii: 10.1007/s00198-019-04900.
    PubMed     Text format     Abstract available


  81. HARVEY NC, Kanis JA, Liu E, Johansson H, et al
    Appendicular lean mass and fracture risk assessment: implications for FRAX(R) and sarcopenia.
    Osteoporos Int. 2019 Feb 27. pii: 10.1007/s00198-019-04904.
    PubMed     Text format    


  82. ADAMI G, Saag KG
    Glucocorticoid-induced osteoporosis: 2019 concise clinical review.
    Osteoporos Int. 2019 Feb 25. pii: 10.1007/s00198-019-04906.
    PubMed     Text format     Abstract available


  83. LORENTZON M, Nilsson AG, Johansson H, Kanis JA, et al
    Extensive undertreatment of osteoporosis in older Swedish women.
    Osteoporos Int. 2019 Feb 25. pii: 10.1007/s00198-019-04872.
    PubMed     Text format     Abstract available


  84. BARTOSCH P, McGuigan FE, Akesson KE
    Correction to: Progression of frailty and prevalence of osteoporosis in a community cohort of older women-a 10-year longitudinal study.
    Osteoporos Int. 2019 Feb 25. pii: 10.1007/s00198-019-04876.
    PubMed     Text format     Abstract available


  85. LI TC, Li CI, Liu CS, Lin WY, et al
    Visit-to-visit blood pressure variability and hip fracture risk in older persons.
    Osteoporos Int. 2019 Feb 21. pii: 10.1007/s00198-019-04899.
    PubMed     Text format     Abstract available



  86. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018-Posters Abstracts.
    Osteoporos Int. 2019 Feb 20. pii: 10.1007/s00198-018-04815.
    PubMed     Text format    


  87. WANG J, Yan D, Zhao A, Hou X, et al
    Discovery of potential biomarkers for osteoporosis using LC-MS/MS metabolomic methods.
    Osteoporos Int. 2019 Feb 18. pii: 10.1007/s00198-019-04892.
    PubMed     Text format     Abstract available


  88. LOPEZ PICAZO M, Humbert L, Di Gregorio S, Gonzalez Ballester MA, et al
    Discrimination of osteoporosis-related vertebral fractures by DXA-derived 3D measurements: a retrospective case-control study.
    Osteoporos Int. 2019 Feb 15. pii: 10.1007/s00198-019-04894.
    PubMed     Text format     Abstract available


  89. ACOSTA-MERIDA A, Ojeda-Bruno S
    Multiple vertebral fractures as the first manifestation of systemic mastocytosis.
    Osteoporos Int. 2019 Feb 15. pii: 10.1007/s00198-019-04897.
    PubMed     Text format     Abstract available


  90. ZHOU Q, Xie F, Zhou B, Wang J, et al
    Differentially expressed proteins identified by TMT proteomics analysis in bone marrow microenvironment of osteoporotic patients.
    Osteoporos Int. 2019 Feb 9. pii: 10.1007/s00198-019-04884.
    PubMed     Text format     Abstract available


  91. KAEWBOONCHOO O, Sung FC, Lin CL, Hsu HC, et al
    Risk of osteoporosis and fracture in victims with burn injury.
    Osteoporos Int. 2019 Feb 8. pii: 10.1007/s00198-018-04818.
    PubMed     Text format     Abstract available


  92. DE BRUIN IJA, Klop C, Wyers CE, Overbeek JA, et al
    All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture.
    Osteoporos Int. 2019 Feb 8. pii: 10.1007/s00198-019-04851.
    PubMed     Text format     Abstract available



  93. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - Oral Communications Abstracts.
    Osteoporos Int. 2019 Feb 8. pii: 10.1007/s00198-018-04814.
    PubMed     Text format    


  94. SU S, He N, Men P, Song C, et al
    The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2019 Feb 7. pii: 10.1007/s00198-019-04853.
    PubMed     Text format     Abstract available


  95. CHEN WJ, Livneh H, Hsieh MH, Yeh CC, et al
    Association of use of Chinese herbal medicines and the risk of fracture in patients with osteoporosis: a population-based cohort study.
    Osteoporos Int. 2019 Feb 5. pii: 10.1007/s00198-018-4789.
    PubMed     Text format     Abstract available


    January 2019
  96. SOLIMEO SL, Nguyen VT, Edmonds SW, Lou Y, et al
    Sex differences in osteoporosis self-efficacy among community-residing older adults presenting for DXA.
    Osteoporos Int. 2019 Jan 30. pii: 10.1007/s00198-019-04854.
    PubMed     Text format     Abstract available


  97. HILIGSMANN M, Reginster JY
    Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France.
    Osteoporos Int. 2019 Jan 30. pii: 10.1007/s00198-018-04821.
    PubMed     Text format     Abstract available



  98. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - Committee of National Societies (CNS) Roundtable Abstracts.
    Osteoporos Int. 2019 Jan 30. pii: 10.1007/s00198-018-04812.
    PubMed     Text format    



  99. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia - 2018 - IOF-OA-ANZBMS Joint Session Abstracts.
    Osteoporos Int. 2019 Jan 28. pii: 10.1007/s00198-018-04811.
    PubMed     Text format    



  100. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - Sponsored Symposia Abstracts.
    Osteoporos Int. 2019 Jan 28. pii: 10.1007/s00198-018-04813.
    PubMed     Text format    



  101. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - Opening ceremony Abstracts.
    Osteoporos Int. 2019 Jan 28. pii: 10.1007/s00198-018-04808.
    PubMed     Text format    



  102. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - Plenary Lecture Abstracts.
    Osteoporos Int. 2019 Jan 28. pii: 10.1007/s00198-018-04807.
    PubMed     Text format    



  103. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - Meet-the-Expert Sessions Abstracts.
    Osteoporos Int. 2019 Jan 28. pii: 10.1007/s00198-018-04809.
    PubMed     Text format    


  104. LYU H, Yoshida K, Tedeschi SK, Zhao S, et al
    Intervals between bone mineral density testing with dual-energy X-ray absorptiometry scans in clinical practice.
    Osteoporos Int. 2019 Jan 24. pii: 10.1007/s00198-019-04847.
    PubMed     Text format     Abstract available


  105. HARDCASTLE SA, Yahya F, Bhalla AK
    Pregnancy-associated osteoporosis: a UK case series and literature review.
    Osteoporos Int. 2019 Jan 23. pii: 10.1007/s00198-019-04842.
    PubMed     Text format     Abstract available


  106. CHEHADE LK, Curragh D, Selva D
    Bisphosphonate-induced orbital inflammation: more common than once thought?
    Osteoporos Int. 2019 Jan 23. pii: 10.1007/s00198-019-04850.
    PubMed     Text format     Abstract available


  107. WANG YXJ, Che-Nordin N, Deng M, Leung JCS, et al
    Osteoporotic vertebral deformity with endplate/cortex fracture is associated with higher further vertebral fracture risk: the Ms. OS (Hong Kong) study results.
    Osteoporos Int. 2019 Jan 22. pii: 10.1007/s00198-019-04856.
    PubMed     Text format     Abstract available



  108. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - IOF-APOA Joint Session Abstracts.
    Osteoporos Int. 2019 Jan 21. pii: 10.1007/s00198-018-04810.
    PubMed     Text format    


  109. NORIEGA DC, Rodriotaguez-Monsalve F, Ramajo R, Sanchez-Lite I, et al
    Correction to: Long-term safety and clinical performance of kyphoplasty and SpineJack(R) procedures in the treatment of osteoporotic vertebral compression fractures: a pilot, monocentric, investigator-initiated study.
    Osteoporos Int. 2019 Jan 18. pii: 10.1007/s00198-018-04825.
    PubMed     Text format     Abstract available


  110. KOLDKJAER SOLLING AS, Harslof T, Langdahl B
    Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis.
    Osteoporos Int. 2019 Jan 17. pii: 10.1007/s00198-018-04833.
    PubMed     Text format     Abstract available


  111. ZHU RS, Kan SL, Ning GZ, Chen LX, et al
    Which is the best treatment of osteoporotic vertebral compression fractures: balloon kyphoplasty, percutaneous vertebroplasty, or non-surgical treatment? A Bayesian network meta-analysis.
    Osteoporos Int. 2019 Jan 12. pii: 10.1007/s00198-018-4804.
    PubMed     Text format     Abstract available


  112. ADAMS AL, Li BH, Bhandari S, Kamat S, et al
    Chronic hyponatremia and association with osteoporosis among a large racially/ethnically diverse population.
    Osteoporos Int. 2019 Jan 11. pii: 10.1007/s00198-018-04832.
    PubMed     Text format     Abstract available


  113. TREISTER-GOLTZMAN Y, Peleg R
    Primary lactase deficiency and bone mineral density in postmenopausal women.
    Osteoporos Int. 2019 Jan 11. pii: 10.1007/s00198-018-4799.
    PubMed     Text format    


  114. NAYAK S, Greenspan SL
    A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk.
    Osteoporos Int. 2019 Jan 8. pii: 10.1007/s00198-018-4791.
    PubMed     Text format     Abstract available


  115. RUDMAN HA, Birrell F, Pearce MS, Tuck SP, et al
    Obesity, bone density relative to body weight and prevalent vertebral fracture at age 62 years: the Newcastle thousand families study.
    Osteoporos Int. 2019 Jan 8. pii: 10.1007/s00198-018-04817.
    PubMed     Text format     Abstract available


  116. NAYLOR KE, McCloskey EV, Jacques RM, Peel NFA, et al
    Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis.
    Osteoporos Int. 2019 Jan 6. pii: 10.1007/s00198-018-04823.
    PubMed     Text format     Abstract available


  117. LAMY O, Fernandez-Fernandez E, Monjo-Henry I, Stoll D, et al
    Alendronate after denosumab discontinuation in women previously exposed to bisphosphonates was not effective in preventing the risk of spontaneous multiple vertebral fractures: two case reports.
    Osteoporos Int. 2019 Jan 6. pii: 10.1007/s00198-018-04820.
    PubMed     Text format     Abstract available


  118. WATSON SL, Weeks BK, Weis LJ, Harding AT, et al
    High-intensity exercise did not cause vertebral fractures and improves thoracic kyphosis in postmenopausal women with low to very low bone mass: the LIFTMOR trial.
    Osteoporos Int. 2019 Jan 5. pii: 10.1007/s00198-018-04829.
    PubMed     Text format     Abstract available


  119. MORIWAKI K, Fukuda H
    Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan.
    Osteoporos Int. 2019 Jan 4. pii: 10.1007/s00198-018-4798.
    PubMed     Text format     Abstract available


  120. BLIUC D, Tran T, van Geel T, Adachi JD, et al
    Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study.
    Osteoporos Int. 2019 Jan 3. pii: 10.1007/s00198-018-4806.
    PubMed     Text format     Abstract available


  121. WANG T, Yang L, Jiang J, Liu Y, et al
    Pulsed electromagnetic fields: promising treatment for osteoporosis.
    Osteoporos Int. 2019 Jan 2. pii: 10.1007/s00198-018-04822.
    PubMed     Text format     Abstract available


  122. BIVER E, Calmy A, Aubry-Rozier B, Birkhauser M, et al
    Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.
    Osteoporos Int. 2019 Jan 2. pii: 10.1007/s00198-018-4794.
    PubMed     Text format     Abstract available


    December 2018
  123. ALTINBAS A
    Osteoporosis risk of the subjects with isolated lactase enzyme deficiency.
    Osteoporos Int. 2018 Dec 18. pii: 10.1007/s00198-018-4736.
    PubMed     Text format    


  124. YANG S, Leslie WD, Morin SN, Lix LM, et al
    Administrative healthcare data applied to fracture risk assessment.
    Osteoporos Int. 2018 Dec 15. pii: 10.1007/s00198-018-4780.
    PubMed     Text format     Abstract available


  125. ELHAKEEM A, Hartley A, Luo Y, Goertzen AL, et al
    Lean mass and lower limb muscle function in relation to hip strength, geometry and fracture risk indices in community-dwelling older women.
    Osteoporos Int. 2018 Dec 14. pii: 10.1007/s00198-018-4795.
    PubMed     Text format     Abstract available


  126. LOU S, Lv H, Yin P, Li Z, et al
    Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2018 Dec 11. pii: 10.1007/s00198-018-4790.
    PubMed     Text format     Abstract available


  127. IKI M, Tamaki J, Sato Y, Winzenrieth R, et al
    Correction to: Age-related normative values of trabecular bone score (TBS) for Japanese women: the Japanese Population-based Osteoporosis (JPOS) study.
    Osteoporos Int. 2018 Dec 11. pii: 10.1007/s00198-018-4779.
    PubMed     Text format     Abstract available


  128. LEE DR, Lee J
    Comparison of the efficacy between once-monthly oral ibandronate and risedronate among Korean women with osteoporosis: a nationwide population-based study.
    Osteoporos Int. 2018 Dec 8. pii: 10.1007/s00198-018-4778.
    PubMed     Text format     Abstract available


  129. CHE H, Breuil V, Cortet B, Paccou J, et al
    Vertebral fractures cascade: potential causes and risk factors.
    Osteoporos Int. 2018 Dec 5. pii: 10.1007/s00198-018-4793.
    PubMed     Text format     Abstract available


  130. ZHU W, Xu C, Zhang JG, He H, et al
    Gene-based GWAS analysis for consecutive studies of GEFOS.
    Osteoporos Int. 2018;29:2645-2658.
    PubMed     Text format     Abstract available


  131. KENDLER DL, Body JJ, Brandi ML, Broady R, et al
    Bone management in hematologic stem cell transplant recipients.
    Osteoporos Int. 2018;29:2597-2610.
    PubMed     Text format     Abstract available


    November 2018
  132. NORIEGA DC
    Long-term safety and clinical performance of kyphoplasty and SpineJack(R) procedures in the treatment of osteoporotic vertebral compression fractures: a pilot, monocentric, investigator-initiated study.
    Osteoporos Int. 2018 Nov 28. pii: 10.1007/s00198-018-4773.
    PubMed     Text format     Abstract available


  133. WU Q
    Depression and antidepressant medications: both are linked to increased fracture risk.
    Osteoporos Int. 2018 Nov 28. pii: 10.1007/s00198-018-4785.
    PubMed     Text format    


  134. PIENKOWSKI D, Wood CL, Malluche HH
    Young's modulus and hardness of human trabecular bone with bisphosphonate treatment durations up to 20 years.
    Osteoporos Int. 2018 Nov 28. pii: 10.1007/s00198-018-4760.
    PubMed     Text format     Abstract available


  135. HOLMBERG T, Moller S, Rothmann MJ, Gram J, et al
    Socioeconomic status and risk of osteoporotic fractures and the use of DXA scans: data from the Danish population-based ROSE study.
    Osteoporos Int. 2018 Nov 21. pii: 10.1007/s00198-018-4768.
    PubMed     Text format     Abstract available


  136. BALASUBRAMANIAN A, Zhang J, Chen L, Wenkert D, et al
    Risk of subsequent fracture after prior fracture among older women.
    Osteoporos Int. 2018 Nov 19. pii: 10.1007/s00198-018-4732.
    PubMed     Text format     Abstract available


  137. YEAM CT, Chia S, Tan HCC, Kwan YH, et al
    A systematic review of factors affecting medication adherence among patients with osteoporosis.
    Osteoporos Int. 2018 Nov 12. pii: 10.1007/s00198-018-4759.
    PubMed     Text format     Abstract available


  138. HAMOOD R, Hamood H, Merhasin I, Keinan-Boker L, et al
    Hormone therapy and osteoporosis in breast cancer survivors: assessment of risk and adherence to screening recommendations.
    Osteoporos Int. 2018 Nov 9. pii: 10.1007/s00198-018-4758.
    PubMed     Text format     Abstract available



  139. Osteoporosis Conference 2018 Birmingham, UK 2 - 4 December 2018 Abstracts.
    Osteoporos Int. 2018 Nov 7. pii: 10.1007/s00198-018-4738.
    PubMed     Text format    


    October 2018
  140. HILIGSMANN M, Reginster JY, Tosteson ANA, Bukata SV, et al
    Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
    Osteoporos Int. 2018 Oct 31. pii: 10.1007/s00198-018-4744.
    PubMed     Text format     Abstract available


  141. LIU B, Wu Q, Zhang S, Del Rosario A, et al
    Lithium use and risk of fracture: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2018 Oct 29. pii: 10.1007/s00198-018-4745.
    PubMed     Text format     Abstract available


  142. YU WB, Jiang XB, Liang D, Xu WX, et al
    Risk factors and score for recollapse of the augmented vertebrae after percutaneous vertebroplasty in osteoporotic vertebral compression fractures.
    Osteoporos Int. 2018 Oct 28. pii: 10.1007/s00198-018-4754.
    PubMed     Text format     Abstract available


  143. TAKACS I, Jokai E, Kovats DE, Aradi I, et al
    The first biosimilar approved for the treatment of osteoporosis: results of a comparative pharmacokinetic/pharmacodynamic study.
    Osteoporos Int. 2018 Oct 24. pii: 10.1007/s00198-018-4741.
    PubMed     Text format     Abstract available


  144. HAIDER IT, Lobos SM, Simonian N, Schnitzer TJ, et al
    Bone fragility after spinal cord injury: reductions in stiffness and bone mineral at the distal femur and proximal tibia as a function of time.
    Osteoporos Int. 2018 Oct 17. pii: 10.1007/s00198-018-4733.
    PubMed     Text format     Abstract available


  145. KANIS JA, Cooper C, Rizzoli R, Reginster JY, et al
    European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Osteoporos Int. 2018 Oct 15. pii: 10.1007/s00198-018-4704.
    PubMed     Text format     Abstract available


  146. TORRES L, Klingberg E, Nurkkala M, Carlsten H, et al
    Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis.
    Osteoporos Int. 2018 Oct 10. pii: 10.1007/s00198-018-4721.
    PubMed     Text format     Abstract available


  147. MERLE B, Dupraz C, Haesebaert J, Barraud L, et al
    Osteoporosis prevention: where are the barriers to improvement in a French general population? A qualitative study.
    Osteoporos Int. 2018 Oct 10. pii: 10.1007/s00198-018-4720.
    PubMed     Text format     Abstract available


  148. ALLAIRE BT, Lu D, Johannesdottir F, Kopperdahl D, et al
    Prediction of incident vertebral fracture using CT-based finite element analysis.
    Osteoporos Int. 2018 Oct 10. pii: 10.1007/s00198-018-4716.
    PubMed     Text format     Abstract available


  149. BIVER E, Pepe J, de Sire A, Chevalley T, et al
    Associations between radius low-frequency axial ultrasound velocity and bone fragility in elderly men and women.
    Osteoporos Int. 2018 Oct 10. pii: 10.1007/s00198-018-4725.
    PubMed     Text format     Abstract available


  150. STOLZENBERG N, Felsenberg D, Belavy DL
    Postural control is associated with muscle power in post-menopausal women with low bone mass.
    Osteoporos Int. 2018;29:2283-2288.
    PubMed     Text format     Abstract available


  151. IRELAND A, Crozier SR, Heazell AEP, Ward KA, et al
    Breech presentation is associated with lower bone mass and area: findings from the Southampton Women's Survey.
    Osteoporos Int. 2018;29:2275-2281.
    PubMed     Text format     Abstract available


    September 2018
  152. KENDLER DL, Chines A, Brandi ML, Papapoulos S, et al
    The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies.
    Osteoporos Int. 2018 Sep 22. pii: 10.1007/s00198-018-4687.
    PubMed     Text format     Abstract available


  153. MCALISTER FA, Ye C, Beaupre LA, Rowe BH, et al
    Adherence to osteoporosis therapy after an upper extremity fracture: a pre-specified substudy of the C-STOP randomized controlled trial.
    Osteoporos Int. 2018 Sep 19. pii: 10.1007/s00198-018-4702.
    PubMed     Text format     Abstract available


  154. KIM J, Kim SW, Lee SY, Kim TH, et al
    Bone mineral density in osteoporotic patients with pyogenic vertebral osteomyelitis: effect of early versus late treatment for osteoporosis.
    Osteoporos Int. 2018 Sep 17. pii: 10.1007/s00198-018-4695.
    PubMed     Text format     Abstract available


  155. AKHTAR ALI S, Ng C, Votava-Smith JK, Randolph LM, et al
    Bisphosphonate therapy in an infant with generalized arterial calcification with an ABCC6 mutation.
    Osteoporos Int. 2018 Sep 11. pii: 10.1007/s00198-018-4639.
    PubMed     Text format     Abstract available


  156. NGUYEN LT, Nguyen UDT, Nguyen TDT, Ho-Pham LT, et al
    Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
    Osteoporos Int. 2018 Sep 8. pii: 10.1007/s00198-018-4700.
    PubMed     Text format     Abstract available


  157. AL-SARI UA, Tobias JH, Clark EM
    Impact of mild and moderate/severe vertebral fractures on physical activity: a prospective study of older women in the UK.
    Osteoporos Int. 2018 Sep 7. pii: 10.1007/s00198-018-4692.
    PubMed     Text format     Abstract available


  158. MIYAOKA D, Imanishi Y, Ohara M, Hayashi N, et al
    Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency.
    Osteoporos Int. 2018 Sep 5. pii: 10.1007/s00198-018-4688.
    PubMed     Text format     Abstract available


  159. DI PAOLA M, Gatti D, Viapiana O, Cianferotti L, et al
    Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck.
    Osteoporos Int. 2018 Sep 4. pii: 10.1007/s00198-018-4686.
    PubMed     Text format     Abstract available


  160. LIU Y, Dimango E, Bucovsky M, Agarwal S, et al
    Abnormal microarchitecture and stiffness in postmenopausal women using chronic inhaled glucocorticoids.
    Osteoporos Int. 2018;29:2121-2127.
    PubMed     Text format     Abstract available


    August 2018
  161. BLATY T, Krueger D, Illgen R, Squire M, et al
    DXA evaluation of femoral bone mineral density and cortical width in patients with prior total knee arthroplasty.
    Osteoporos Int. 2018 Aug 31. pii: 10.1007/s00198-018-4682.
    PubMed     Text format     Abstract available


  162. SOKAL A, Elefant E, Leturcq T, Beghin D, et al
    Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study.
    Osteoporos Int. 2018 Aug 31. pii: 10.1007/s00198-018-4672.
    PubMed     Text format     Abstract available


  163. HALASI A, Kincse G, Varga J, Keri J, et al
    Tight control: a new therapeutic strategy in the management of osteoporotic patients.
    Osteoporos Int. 2018 Aug 30. pii: 10.1007/s00198-018-4674.
    PubMed     Text format     Abstract available


  164. LIU C, Wang L, Zhu R, Liu H, et al
    Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/beta-catenin signaling pathway in OVX rats.
    Osteoporos Int. 2018 Aug 27. pii: 10.1007/s00198-018-4670.
    PubMed     Text format     Abstract available


  165. SHIMIZU Y, Sawada N, Nakamura K, Watanabe Y, et al
    Menstrual and reproductive factors and risk of vertebral fractures in Japanese women: the Japan Public Health Center-based prospective (JPHC) study.
    Osteoporos Int. 2018 Aug 24. pii: 10.1007/s00198-018-4665.
    PubMed     Text format     Abstract available


  166. BARZILAY JI, Buzkova P, Cauley JA, Robbins JA, et al
    The associations of subclinical atherosclerotic cardiovascular disease with hip fracture risk and bone mineral density in elderly adults.
    Osteoporos Int. 2018 Aug 21. pii: 10.1007/s00198-018-4611.
    PubMed     Text format     Abstract available


  167. HAUGER AV, Bergland A, Holvik K, Stahle A, et al
    Osteoporosis and osteopenia in the distal forearm predict all-cause mortality independent of grip strength: 22-year follow-up in the population-based Tromso Study.
    Osteoporos Int. 2018 Aug 9. pii: 10.1007/s00198-018-4653.
    PubMed     Text format     Abstract available


  168. MAZZUCCHELLI R, Crespi Villarias N, Perez Fernandez E, Durban Reguera ML, et al
    Short-term association between outdoor air pollution and osteoporotic hip fracture.
    Osteoporos Int. 2018 Aug 9. pii: 10.1007/s00198-018-4605.
    PubMed     Text format     Abstract available


  169. XU Y, Wu Q
    Decreasing trend of bone mineral density in US multiethnic population: analysis of continuous NHANES 2005-2014.
    Osteoporos Int. 2018 Aug 8. pii: 10.1007/s00198-018-4648.
    PubMed     Text format     Abstract available


  170. GIANGREGORIO LM, Gibbs JC, Templeton JA, Adachi JD, et al
    Build better bones with exercise (B3E pilot trial): results of a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in older women with vertebral fracture.
    Osteoporos Int. 2018 Aug 8. pii: 10.1007/s00198-018-4652.
    PubMed     Text format     Abstract available


  171. ZHANG YS, Weng WY, Xie BC, Meng Y, et al
    Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials.
    Osteoporos Int. 2018 Aug 6. pii: 10.1007/s00198-018-4649.
    PubMed     Text format     Abstract available


  172. GAMBOA A, Duaso E, Marimon P, Sandiumenge M, et al
    Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit.
    Osteoporos Int. 2018 Aug 3. pii: 10.1007/s00198-018-4622.
    PubMed     Text format     Abstract available


  173. JIANG N, Xia W
    Assessment of bone quality in patients with diabetes mellitus.
    Osteoporos Int. 2018;29:1721-1736.
    PubMed     Text format     Abstract available


    July 2018
  174. FERRARI SL, Abrahamsen B, Napoli N, Akesson K, et al
    Diagnosis and management of bone fragility in diabetes: an emerging challenge.
    Osteoporos Int. 2018 Jul 31. pii: 10.1007/s00198-018-4650.
    PubMed     Text format     Abstract available


  175. MUNHOZ DA ROCHA LEMOS COSTA T, Costa FM, Hoffman Jonasson T, Aguiar Moreira C, et al
    Bone mineral density and vertebral fractures and their relationship with pulmonary dysfunction in patients with chronic obstructive pulmonary disease.
    Osteoporos Int. 2018 Jul 25. pii: 10.1007/s00198-018-4643.
    PubMed     Text format     Abstract available


  176. HIDAYAT K, Du X, Shi BM
    Sex hormone-binding globulin and risk of fracture in older adults: systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2018 Jul 24. pii: 10.1007/s00198-018-4600.
    PubMed     Text format     Abstract available


  177. LIM SJ, Yeo I, Yoon PW, Yoo JJ, et al
    Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study.
    Osteoporos Int. 2018 Jul 23. pii: 10.1007/s00198-018-4640.
    PubMed     Text format     Abstract available


  178. KYVERNITAKIS I, Kostev K, Hadji P
    The tamoxifen paradox-influence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer.
    Osteoporos Int. 2018 Jul 21. pii: 10.1007/s00198-018-4642.
    PubMed     Text format     Abstract available


  179. SONG LJ, Wang LL, Ning L, Fan SW, et al
    A modification and validation of quantitative morphometry classification system for osteoporotic vertebral compressive fractures in mainland Chinese.
    Osteoporos Int. 2018 Jul 20. pii: 10.1007/s00198-018-4641.
    PubMed     Text format     Abstract available


  180. KANAZAWA I, Notsu M, Miyake H, Tanaka K, et al
    Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus.
    Osteoporos Int. 2018 Jul 20. pii: 10.1007/s00198-018-4638.
    PubMed     Text format     Abstract available


  181. NORDKLINT AK, Almdal TP, Vestergaard P, Lundby-Christensen L, et al
    The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial.
    Osteoporos Int. 2018 Jul 19. pii: 10.1007/s00198-018-4637.
    PubMed     Text format     Abstract available


  182. LIU J, Guo H, Rai P, Pinto L, et al
    Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis.
    Osteoporos Int. 2018 Jul 18. pii: 10.1007/s00198-018-4630.
    PubMed     Text format     Abstract available


  183. CHOI CK, Kweon S-, Lee Y-, Nam H-, et al
    Nonlinear association between bone mineral density and all-cause mortality: the Dong-gu study.
    Osteoporos Int. 2018 Jul 16. pii: 10.1007/s00198-018-4386.
    PubMed     Text format     Abstract available


  184. BERGMAN J, Nordstrom A, Nordstrom P
    Bisphosphonate use after clinical fracture and risk of new fracture: response to comments by Wu et al.
    Osteoporos Int. 2018 Jul 16. pii: 10.1007/s00198-018-4615.
    PubMed     Text format    


  185. TREISTER-GOLTZMAN Y, Friger M, Peleg R
    Does primary lactase deficiency reduce bone mineral density in postmenopausal women? A systematic review and meta-analysis.
    Osteoporos Int. 2018 Jul 16. pii: 10.1007/s00198-018-4635.
    PubMed     Text format     Abstract available


  186. CHRISTIANSEN BA, Harrison SL, Fink HA, Lane NE, et al
    Incident fracture is associated with a period of accelerated loss of hip BMD: the Study of Osteoporotic Fractures.
    Osteoporos Int. 2018 Jul 10. pii: 10.1007/s00198-018-4606.
    PubMed     Text format     Abstract available


  187. VELLUCCI R, Terenzi R, Kanis JA, Kress HG, et al
    Understanding osteoporotic pain and its pharmacological treatment: supplementary presentation.
    Osteoporos Int. 2018 Jul 10. pii: 10.1007/s00198-018-4536.
    PubMed     Text format     Abstract available


  188. MO XB, Zhang YH, Lei SF
    Genome-wide identification of m(6)A-associated SNPs as potential functional variants for bone mineral density.
    Osteoporos Int. 2018 Jul 7. pii: 10.1007/s00198-018-4573.
    PubMed     Text format     Abstract available


  189. AMORIM T, Duraes C, Machado JC, Metsios GS, et al
    Genetic variation in Wnt/beta-catenin and ER signalling pathways in female and male elite dancers and its associations with low bone mineral density: a cross-section and longitudinal study.
    Osteoporos Int. 2018 Jul 5. pii: 10.1007/s00198-018-4610.
    PubMed     Text format     Abstract available


  190. WU QY, Yuan FL, Wang B, Li X, et al
    Comments on Bergman et al.: Bisphosphonate use after clinical fracture and risk of new fracture.
    Osteoporos Int. 2018 Jul 5. pii: 10.1007/s00198-018-4614.
    PubMed     Text format    


  191. WINZENRIETH R, Humbert L, Di Gregorio S, Bonel E, et al
    Effects of osteoporosis drug treatments on cortical and trabecular bone in the femur using DXA-based 3D modeling.
    Osteoporos Int. 2018 Jul 4. pii: 10.1007/s00198-018-4624.
    PubMed     Text format     Abstract available


  192. GALLI S, Stocchero M, Andersson M, Karlsson J, et al
    Correction to: The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation.
    Osteoporos Int. 2018 Jul 3. pii: 10.1007/s00198-018-4497.
    PubMed     Text format     Abstract available


  193. HO-PHAM LT, Chau PMN, Do AT, Nguyen HC, et al
    Type 2 diabetes is associated with higher trabecular bone density but lower cortical bone density: the Vietnam Osteoporosis Study.
    Osteoporos Int. 2018 Jul 2. pii: 10.1007/s00198-018-4579.
    PubMed     Text format     Abstract available


  194. SHUDO A, Kishimoto H, Takaoka K, Noguchi K, et al
    Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.
    Osteoporos Int. 2018 Jul 2. pii: 10.1007/s00198-018-4621.
    PubMed     Text format     Abstract available


    June 2018
  195. LIU LC, Lu MC, Wang SY, Livneh H, et al
    Association of use of rehabilitation services with development of osteoporosis among patients with rheumatoid arthritis: a nationwide population-based cohort study.
    Osteoporos Int. 2018 Jun 27. pii: 10.1007/s00198-018-4569.
    PubMed     Text format     Abstract available


  196. SMITH BJ, Leyva MJ, Stephens LD, Aston CE, et al
    Relationship of American Indian blood quantum with osteoporosis risk: a cross-sectional study of American Indian women in Oklahoma.
    Osteoporos Int. 2018 Jun 25. pii: 10.1007/s00198-018-4594.
    PubMed     Text format     Abstract available


  197. GIORDANO S, Proietti A, Bisaccia T, Caso P, et al
    Hypovitaminosis D: comparison between patients with hip fracture and patients with vertebral fractures.
    Osteoporos Int. 2018 Jun 23. pii: 10.1007/s00198-018-4582.
    PubMed     Text format     Abstract available


  198. YOSHIMURA N, Muraki S, Oka H, Iidaka T, et al
    Do sarcopenia and/or osteoporosis increase the risk of frailty? A 4-year observation of the second and third ROAD study surveys.
    Osteoporos Int. 2018 Jun 21. pii: 10.1007/s00198-018-4596.
    PubMed     Text format     Abstract available


  199. SZAFORS P, Che H, Barnetche T, Morel J, et al
    Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis.
    Osteoporos Int. 2018 Jun 16. pii: 10.1007/s00198-018-4586.
    PubMed     Text format     Abstract available


  200. CHEN H, Lips P, Vervloet MG, van Schoor NM, et al
    Association of renal function with bone mineral density and fracture risk in the Longitudinal Aging Study Amsterdam.
    Osteoporos Int. 2018 Jun 15. pii: 10.1007/s00198-018-4592.
    PubMed     Text format     Abstract available


  201. BARTOSCH P, McGuigan FE, Akesson KE
    Progression of frailty and prevalence of osteoporosis in a community cohort of older women-a 10-year longitudinal study.
    Osteoporos Int. 2018 Jun 12. pii: 10.1007/s00198-018-4593.
    PubMed     Text format     Abstract available


  202. HARVEY NC, McCloskey E, Kanis JA, Compston J, et al
    Cost-effective but clinically inappropriate: new NICE intervention thresholds in osteoporosis (Technology Appraisal 464).
    Osteoporos Int. 2018 Jun 8. pii: 10.1007/s00198-018-4505.
    PubMed     Text format     Abstract available


  203. KANIS JA, Cooper C, Rizzoli R, Reginster JY, et al
    Review of the guideline of the American College of Physicians on the treatment of osteoporosis.
    Osteoporos Int. 2018 Jun 4. pii: 10.1007/s00198-018-4504.
    PubMed     Text format     Abstract available


  204. GUPTA MJ, Shah S, Peterson S, Baim S, et al
    Rush Fracture Liaison Service for capturing "missed opportunities" to treat osteoporosis in patients with fragility fractures.
    Osteoporos Int. 2018 Jun 4. pii: 10.1007/s00198-018-4559.
    PubMed     Text format     Abstract available


  205. RIKKONEN T, Poole K, Sirola J, Sund R, et al
    Long-term effects of functional impairment on fracture risk and mortality in postmenopausal women.
    Osteoporos Int. 2018 Jun 2. pii: 10.1007/s00198-018-4588.
    PubMed     Text format     Abstract available


  206. LOSADA E, Soldevila B, Ali MS, Martinez-Laguna D, et al
    Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
    Osteoporos Int. 2018 Jun 2. pii: 10.1007/s00198-018-4581.
    PubMed     Text format     Abstract available


  207. KIM SJ, Park HS, Lee DW, Lee JW, et al
    Is calcium phosphate augmentation a viable option for osteoporotic hip fractures?
    Osteoporos Int. 2018 Jun 1. pii: 10.1007/s00198-018-4572.
    PubMed     Text format     Abstract available


  208. CARLSON BC, Robinson WA, Wanderman NR, Nassr AN, et al
    The American Orthopaedic Association's Own the Bone(R) database: a national quality improvement project for the treatment of bone health in fragility fracture patients.
    Osteoporos Int. 2018 Jun 1. pii: 10.1007/s00198-018-4585.
    PubMed     Text format     Abstract available


  209. JAIN RK, Vokes T
    Association of trabecular bone score (TBS) and prior fracture differs among minorities in NHANES 2005-2008.
    Osteoporos Int. 2018 Jun 1. pii: 10.1007/s00198-018-4584.
    PubMed     Text format     Abstract available


    May 2018
  210. CAI X, Yi X, Zhang Y, Zhang D, et al
    Genetic susceptibility of postmenopausal osteoporosis on sulfide quinone reductase-like gene.
    Osteoporos Int. 2018 May 31. pii: 10.1007/s00198-018-4575.
    PubMed     Text format     Abstract available


  211. LENCHIK L, Register TC, Russell GB, Xu J, et al
    Volumetric bone mineral density of the spine predicts mortality in African-American men with type 2 diabetes.
    Osteoporos Int. 2018 May 31. pii: 10.1007/s00198-018-4578.
    PubMed     Text format     Abstract available


  212. HOFF M, Skurtveit S, Meyer HE, Langhammer A, et al
    Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway.
    Osteoporos Int. 2018 May 17. pii: 10.1007/s00198-018-4560.
    PubMed     Text format     Abstract available


  213. SU Y, Lai FTT, Yip BHK, Leung JCS, et al
    Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.
    Osteoporos Int. 2018 May 17. pii: 10.1007/s00198-018-4543.
    PubMed     Text format     Abstract available


  214. NGUYEN ET, Posas-Mendoza T, Siu AM, Ahn HJ, et al
    Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii.
    Osteoporos Int. 2018 May 9. pii: 10.1007/s00198-018-4553.
    PubMed     Text format     Abstract available


  215. RIZZOLI R, Biver E, Bonjour JP, Coxam V, et al
    Benefits and safety of dietary protein for bone health-an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis
    Osteoporos Int. 2018 May 8. pii: 10.1007/s00198-018-4534.
    PubMed     Text format     Abstract available


  216. GOH SSL, Lai PSM, Tan ATB, Ponnampalavanar S, et al
    Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors: supplementary presentation.
    Osteoporos Int. 2018 May 8. pii: 10.1007/s00198-018-4379.
    PubMed     Text format     Abstract available


  217. BIVER E, Durosier-Izart C, Merminod F, Chevalley T, et al
    Fermented dairy products consumption is associated with attenuated cortical bone loss independently of total calcium, protein, and energy intakes in healthy postmenopausal women.
    Osteoporos Int. 2018 May 3. pii: 10.1007/s00198-018-4535.
    PubMed     Text format     Abstract available


  218. XIAO X, Roohani D, Wu Q
    Genetic profiling of decreased bone mineral density in an independent sample of Caucasian women.
    Osteoporos Int. 2018 May 1. pii: 10.1007/s00198-018-4546.
    PubMed     Text format     Abstract available


  219. LOCQUET M, Beaudart C, Bruyere O, Kanis JA, et al
    Bone health assessment in older people with or without muscle health impairment.
    Osteoporos Int. 2018;29:1057-1067.
    PubMed     Text format     Abstract available


  220. ZIEBART C, McArthur C, Lee L, Papaioannou A, et al
    "Left to my own devices, I don't know": using theory and patient-reported barriers to move from physical activity recommendations to practice.
    Osteoporos Int. 2018;29:1081-1091.
    PubMed     Text format     Abstract available


    April 2018
  221. THONGPRAYOON C, Acharya P, Acharya C, Chenbhanich J, et al
    Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.
    Osteoporos Int. 2018 Apr 30. pii: 10.1007/s00198-018-4533.
    PubMed     Text format     Abstract available


  222. INDERJEETH CA, Raymond WD, Briggs AM, Geelhoed E, et al
    Implementation of the Western Australian Osteoporosis Model of Care: a fracture liaison service utilising emergency department information systems to identify patients with fragility fracture to improve current practice and reduce re-fracture rates: a
    Osteoporos Int. 2018 Apr 27. pii: 10.1007/s00198-018-4526.
    PubMed     Text format     Abstract available


  223. AHMADI N, Mao SS, Hajsadeghi F, Arnold B, et al
    The relation of low levels of bone mineral density with coronary artery calcium and mortality.
    Osteoporos Int. 2018 Apr 27. pii: 10.1007/s00198-018-4524.
    PubMed     Text format     Abstract available


  224. SHI M, Chen L, Xin Z, Wang Y, et al
    Bisphosphonates for the preservation of periprosthetic bone mineral density after total joint arthroplasty: a meta-analysis of 25 randomized controlled trials.
    Osteoporos Int. 2018 Apr 13. pii: 10.1007/s00198-018-4488.
    PubMed     Text format     Abstract available


  225. SU Y, Leung J, Kwok T
    The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2018 Apr 12. pii: 10.1007/s00198-017-4373.
    PubMed     Text format     Abstract available


  226. CLARK EM, Gooberman-Hill R, Peters TJ
    Correction to: Using self-reports of pain and other variables to distinguish between older women with back pain due to vertebral fractures and those with back pain due to degenerative changes.
    Osteoporos Int. 2018 Apr 12. pii: 10.1007/s00198-018-4495.
    PubMed     Text format     Abstract available


  227. KOSTEV K
    Association between gout and osteoporosis risk in the United Kingdom.
    Osteoporos Int. 2018 Apr 10. pii: 10.1007/s00198-018-4477.
    PubMed     Text format    


  228. KOK VC
    Gout as a risk factor for osteoporosis: response to comments by Kostev.
    Osteoporos Int. 2018 Apr 10. pii: 10.1007/s00198-018-4478.
    PubMed     Text format    


  229. LIU Y, Levack AE, Marty E, Or O, et al
    Anabolic agents: what is beyond osteoporosis?
    Osteoporos Int. 2018 Apr 7. pii: 10.1007/s00198-018-4507.
    PubMed     Text format     Abstract available


  230. KEMMLER W, Shojaa M, Kohl M, von Stengel S, et al
    Exercise effects on bone mineral density in older men: a systematic review with special emphasis on study interventions.
    Osteoporos Int. 2018 Apr 5. pii: 10.1007/s00198-018-4482.
    PubMed     Text format     Abstract available


  231. VELLUCCI R, Terenzi R, Kanis JA, Kress HG, et al
    Understanding osteoporotic pain and its pharmacological treatment.
    Osteoporos Int. 2018 Apr 4. pii: 10.1007/s00198-018-4476.
    PubMed     Text format     Abstract available



  232. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  233. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Author Index.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  234. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): ESCEO Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  235. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Plenary Lectures Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  236. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Educational Lecture Abstract.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  237. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): IOF-ESCEO Symposium Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  238. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Satellite Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  239. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): ESCEO-WHO Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  240. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Oral Communication Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  241. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): EUGMS-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  242. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): ESPRM-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  243. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Meet-the-Expert Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  244. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Non-Sponsored Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  245. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Committee of National Societies Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    


  246. ROSEVEARE D
    World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Poster Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    


  247. T YIN M, RoyChoudhury A, Nishiyama K, Lang T, et al
    Bone density and microarchitecture in hepatitis C and HIV-coinfected postmenopausal minority women.
    Osteoporos Int. 2018;29:871-879.
    PubMed     Text format     Abstract available


  248. SHEN CL, Yang S, Tomison MD, Romero AW, et al
    Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial.
    Osteoporos Int. 2018;29:881-891.
    PubMed     Text format     Abstract available


    March 2018
  249. BUTSCHEIDT S, Delsmann A, Rolvien T, Barvencik F, et al
    Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2.
    Osteoporos Int. 2018 Mar 29. pii: 10.1007/s00198-018-4499.
    PubMed     Text format     Abstract available


  250. WANG D, Ruan W, Peng Y, Li W, et al
    Sleep duration and the risk of osteoporosis among middle-aged and elderly adults: a dose-response meta-analysis.
    Osteoporos Int. 2018 Mar 25. pii: 10.1007/s00198-018-4487.
    PubMed     Text format     Abstract available


  251. XIAO X, Xu Y, Wu Q
    Thiazide diuretic usage and risk of fracture: a meta-analysis of cohort studies.
    Osteoporos Int. 2018 Mar 25. pii: 10.1007/s00198-018-4486.
    PubMed     Text format     Abstract available


  252. KUMAGAI K, Harigane K, Kusayama Y, Tezuka T, et al
    Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison.
    Osteoporos Int. 2018 Mar 24. pii: 10.1007/s00198-018-4494.
    PubMed     Text format     Abstract available


  253. EBINA K, Hirao M, Hashimoto J, Matsuoka H, et al
    Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naive rheumatoid arthritis.
    Osteoporos Int. 2018 Mar 24. pii: 10.1007/s00198-018-4492.
    PubMed     Text format     Abstract available


  254. GRAUMAM RQ, Pinheiro MM, Nery LE, Castro CHM, et al
    Increased rate of osteoporosis, low lean mass, and fragility fractures in COPD patients: association with disease severity.
    Osteoporos Int. 2018 Mar 21. pii: 10.1007/s00198-018-4483.
    PubMed     Text format     Abstract available


  255. ALEKSOVA J, Kurniawan S, Elder GJ
    The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.
    Osteoporos Int. 2018 Mar 19. pii: 10.1007/s00198-018-4468.
    PubMed     Text format     Abstract available


  256. WU Q, Liu B, Tonmoy S
    Depression and risk of fracture and bone loss: an updated meta-analysis of prospective studies.
    Osteoporos Int. 2018 Mar 12. pii: 10.1007/s00198-018-4420.
    PubMed     Text format     Abstract available


  257. NAYLOR KE, Bradburn M, Paggiosi MA, Gossiel F, et al
    Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density.
    Osteoporos Int. 2018 Mar 10. pii: 10.1007/s00198-018-4460.
    PubMed     Text format     Abstract available


  258. WU CH, Chen CH, Chen PH, Yang JJ, et al
    Identifying characteristics of an effective fracture liaison service: systematic literature review.
    Osteoporos Int. 2018 Mar 10. pii: 10.1007/s00198-017-4370.
    PubMed     Text format     Abstract available


  259. LEVIN VA, Jiang X, Kagan R
    Estrogen therapy for osteoporosis in the modern era.
    Osteoporos Int. 2018 Mar 8. pii: 10.1007/s00198-018-4414.
    PubMed     Text format     Abstract available


  260. LUO Y
    Bone mineral density averaged over a region of interest on femur is affected by age-related change of bone geometry.
    Osteoporos Int. 2018 Mar 5. pii: 10.1007/s00198-018-4461.
    PubMed     Text format     Abstract available


  261. SEGAUD N, Legroux I, Hazzan M, Noel C, et al
    Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
    Osteoporos Int. 2018 Mar 2. pii: 10.1007/s00198-018-4383.
    PubMed     Text format     Abstract available


  262. LESLIE WD, Shevroja E, Johansson H, McCloskey EV, et al
    Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD registry.
    Osteoporos Int. 2018;29:751-758.
    PubMed     Text format     Abstract available


  263. SHAH VN, Sippl R, Joshee P, Pyle L, et al
    Trabecular bone quality is lower in adults with type 1 diabetes and is negatively associated with insulin resistance.
    Osteoporos Int. 2018;29:733-739.
    PubMed     Text format     Abstract available


  264. WANG Z, Wang D, Yang D, Zhen W, et al
    The effect of icariin on bone metabolism and its potential clinical application.
    Osteoporos Int. 2018;29:535-544.
    PubMed     Text format     Abstract available


    February 2018
  265. UENISHI K, Tokiwa M, Kato S, Shiraki M, et al
    Correction to: Stimulation of intestinal calcium absorption by orally administrated vitamin D3 compounds: a prospective open-label randomized trial in osteoporosis.
    Osteoporos Int. 2018 Feb 26. pii: 10.1007/s00198-018-4449.
    PubMed     Text format     Abstract available


  266. UEI H, Tokuhashi Y, Maseda M, Nakahashi M, et al
    Multiple vertebral fractures associated with glucocorticoid-induced osteoporosis treated with teriparatide followed by kyphosis correction fusion: a case report.
    Osteoporos Int. 2018 Feb 23. pii: 10.1007/s00198-018-4425.
    PubMed     Text format     Abstract available


  267. GUIRANT L, Carlos F, Curiel D, Kanis JA, et al
    Health-related quality of life during the first year after a hip fracture: results of the Mexican arm of the International Cost and Utility Related to Osteoporotic Fractures Study (MexICUROS).
    Osteoporos Int. 2018 Feb 20. pii: 10.1007/s00198-018-4389.
    PubMed     Text format     Abstract available


  268. KUIPER BW, Graybill S, Tate JM, Kaufman N, et al
    After the fall: improving osteoporosis treatment following hip fracture.
    Osteoporos Int. 2018 Feb 20. pii: 10.1007/s00198-018-4416.
    PubMed     Text format     Abstract available


  269. MARCUS R
    Comments on Galli et al.: The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-017-4177.
    PubMed     Text format    


  270. LEE CK, Choi SK, Shin DA, Yi S, et al
    Parkinson's disease and the risk of osteoporotic vertebral compression fracture: a nationwide population-based study.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4409.
    PubMed     Text format     Abstract available


  271. KARJALAINEN JP, Riekkinen O, Kroger H
    Pulse-echo ultrasound method for detection of post-menopausal women with osteoporotic BMD.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4408.
    PubMed     Text format     Abstract available


  272. GALLI S
    The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation: response to comments by Marcus.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4430.
    PubMed     Text format    


  273. BINKLEY N, Krueger D, de Papp AE
    Multiple vertebral fractures following osteoporosis treatment discontinuation: a case-report after long-term Odanacatib.
    Osteoporos Int. 2018 Feb 18. pii: 10.1007/s00198-018-4385.
    PubMed     Text format     Abstract available


  274. ROGERS TS, Harrison S, Judd S, Orwoll ES, et al
    Dietary patterns and longitudinal change in hip bone mineral density among older men.
    Osteoporos Int. 2018 Feb 15. pii: 10.1007/s00198-018-4388.
    PubMed     Text format     Abstract available


  275. ROUX S, Gaboury I, Gionet-Landry N, Garant MP, et al
    Using a sequential explanatory mixed method to evaluate the therapeutic window of opportunity for initiating osteoporosis treatment following fragility fractures.
    Osteoporos Int. 2018 Feb 14. pii: 10.1007/s00198-017-4374.
    PubMed     Text format     Abstract available


  276. ZHOU C, Fang L, Chen Y, Zhong J, et al
    Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
    Osteoporos Int. 2018 Feb 12. pii: 10.1007/s00198-018-4413.
    PubMed     Text format     Abstract available


  277. GREENSPAN SL, Singer A, Vujevich K, Marchand B, et al
    Implementing a fracture liaison service open model of care utilizing a cloud-based tool.
    Osteoporos Int. 2018 Feb 10. pii: 10.1007/s00198-017-4371.
    PubMed     Text format     Abstract available


  278. MORI Y, Kasai H, Ose A, Serada M, et al
    Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
    Osteoporos Int. 2018 Feb 8. pii: 10.1007/s00198-018-4376.
    PubMed     Text format     Abstract available


  279. LESLIE WD, Majumdar SR, Morin SN, Lix LM, et al
    Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
    Osteoporos Int. 2018 Feb 5. pii: 10.1007/s00198-018-4415.
    PubMed     Text format     Abstract available



  280. Erratum to: World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Poster Abstracts.
    Osteoporos Int. 2018 Feb 5. pii: 10.1007/s00198-017-4135.
    PubMed     Text format     Abstract available


  281. HAMDY RC, Seier E, Whalen K, Clark WA, et al
    FRAX calculated without BMD does not correctly identify Caucasian men with densitometric evidence of osteoporosis.
    Osteoporos Int. 2018 Feb 3. pii: 10.1007/s00198-017-4368.
    PubMed     Text format     Abstract available


  282. BERGMAN J, Nordstrom A, Nordstrom P
    Bisphosphonate use after clinical fracture and risk of new fracture.
    Osteoporos Int. 2018 Feb 3. pii: 10.1007/s00198-017-4367.
    PubMed     Text format     Abstract available


  283. BILEZIKIAN JP, Hattersley G, Fitzpatrick LA, Harris AG, et al
    Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.
    Osteoporos Int. 2018;29:323-328.
    PubMed     Text format     Abstract available


  284. OSIMA M, Borgen TT, Lukic M, Grimnes G, et al
    Serum parathyroid hormone is associated with increased cortical porosity of the inner transitional zone at the proximal femur in postmenopausal women: the Tromso Study.
    Osteoporos Int. 2018;29:421-431.
    PubMed     Text format     Abstract available


    January 2018
  285. KOK VC, Horng JT, Wang MN, Chen ZY, et al
    Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals.
    Osteoporos Int. 2018 Jan 30. pii: 10.1007/s00198-018-4375.
    PubMed     Text format     Abstract available


  286. WRIGHT NC, Hooker ER, Nielson CM, Ensrud KE, et al
    The epidemiology of wrist fractures in older men: the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2018 Jan 17. pii: 10.1007/s00198-017-4349.
    PubMed     Text format     Abstract available


  287. NEWMAN M, Newman R, Hughes T, Vadher K, et al
    Is the timed loaded standing test a valid measure of back muscle endurance in people with vertebral osteoporosis?
    Osteoporos Int. 2018 Jan 10. pii: 10.1007/s00198-017-4358.
    PubMed     Text format     Abstract available


  288. MOOKIAH MRK, Rohrmeier A, Dieckmeyer M, Mei K, et al
    Feasibility of opportunistic osteoporosis screening in routine contrast-enhanced multi detector computed tomography (MDCT) using texture analysis.
    Osteoporos Int. 2018 Jan 10. pii: 10.1007/s00198-017-4342.
    PubMed     Text format     Abstract available


  289. VARAHRA A, Rodrigues IB, MacDermid JC, Bryant D, et al
    Exercise to improve functional outcomes in persons with osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2018 Jan 6. pii: 10.1007/s00198-017-4339.
    PubMed     Text format     Abstract available


  290. GIFRE L, Humbert L, Muxi A, Del Rio L, et al
    Analysis of the evolution of cortical and trabecular bone compartments in the proximal femur after spinal cord injury by 3D-DXA.
    Osteoporos Int. 2018;29:201-209.
    PubMed     Text format     Abstract available


  291. BELAYA ZE, Grebennikova TA, Melnichenko GA, Nikitin AG, et al
    Effects of endogenous hypercortisolism on bone mRNA and microRNA expression in humans.
    Osteoporos Int. 2018;29:211-221.
    PubMed     Text format     Abstract available


  292. LESLIE WD, Morin SN, Majumdar SR, Lix LM, et al
    Effects of obesity and diabetes on rate of bone density loss.
    Osteoporos Int. 2018;29:61-67.
    PubMed     Text format     Abstract available


    December 2017
  293. CHANG Y-, Huang C-, Hwang J-, Kuo J-, et al
    Fracture liaison services for osteoporosis in the Asia-Pacific region: current unmet needs and systematic literature review.
    Osteoporos Int. 2017 Dec 28. pii: 10.1007/s00198-017-4347.
    PubMed     Text format     Abstract available


  294. MICHAEL LEWIECKI E, Wright NC, Curtis JR, Siris E, et al
    Hip fracture trends in the United States, 2002 to 2015.
    Osteoporos Int. 2017 Dec 27. pii: 10.1007/s00198-017-4345.
    PubMed     Text format     Abstract available


  295. UENISHI K, Tokiwa M, Kato S, Shiraki M, et al
    Stimulation of intestinal calcium absorption by orally administrated vitamin D3 compounds: a prospective open-label randomized trial in osteoporosis.
    Osteoporos Int. 2017 Dec 23. pii: 10.1007/s00198-017-4351.
    PubMed     Text format     Abstract available


  296. TAMIMI I, Nicolau B, Eimar H, Arekunnath Madathil S, et al
    Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study.
    Osteoporos Int. 2017 Dec 20. pii: 10.1007/s00198-017-4346.
    PubMed     Text format     Abstract available


  297. LUTHMAN S, Widen J, Borgstrom F
    Appropriateness criteria for treatment of osteoporotic vertebral compression fractures.
    Osteoporos Int. 2017 Dec 19. pii: 10.1007/s00198-017-4348.
    PubMed     Text format     Abstract available


  298. VAN DEN BERG P, van Haard PMM, van der Veer E, Geusens PP, et al
    A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates.
    Osteoporos Int. 2017 Dec 19. pii: 10.1007/s00198-017-4340.
    PubMed     Text format     Abstract available


  299. HTET TD, Eisman JA, Elder GJ, Center JR, et al
    Worsening of soft tissue dystrophic calcification in an osteoporotic patient treated with teriparatide.
    Osteoporos Int. 2017 Dec 15. pii: 10.1007/s00198-017-4330.
    PubMed     Text format     Abstract available


  300. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis.
    Osteoporos Int. 2017 Dec 11. pii: 10.1007/s00198-017-4334.
    PubMed     Text format     Abstract available


  301. RUBIN KH, Rothmann MJ, Holmberg T, Hoiberg M, et al
    Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study.
    Osteoporos Int. 2017 Dec 7. pii: 10.1007/s00198-017-4326.
    PubMed     Text format     Abstract available


  302. WATANABE R, Shiraki M, Saito M, Okazaki R, et al
    Restrictive pulmonary dysfunction is associated with vertebral fractures and bone loss in elderly postmenopausal women.
    Osteoporos Int. 2017 Dec 7. pii: 10.1007/s00198-017-4337.
    PubMed     Text format     Abstract available


  303. BOSKEY AL, Spevak L, Ma Y, Wang H, et al
    Insights into the bisphosphonate holiday: a preliminary FTIRI study.
    Osteoporos Int. 2017 Dec 5. pii: 10.1007/s00198-017-4324.
    PubMed     Text format     Abstract available


  304. MARTIN-MERINO E, Petersen I, Hawley S, Alvarez-Gutierrez A, et al
    Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK.
    Osteoporos Int. 2017 Dec 3. pii: 10.1007/s00198-017-4308.
    PubMed     Text format     Abstract available


  305. AREECKAL AS, Jayasheelan N, Kamath J, Zawadynski S, et al
    Early diagnosis of osteoporosis using radiogrammetry and texture analysis from hand and wrist radiographs in Indian population.
    Osteoporos Int. 2017 Dec 3. pii: 10.1007/s00198-017-4328.
    PubMed     Text format     Abstract available


  306. JONSSON E, Hansson-Hedblom A, Ljunggren O, Akesson K, et al
    A health economic simulation model for the clinical management of osteoporosis.
    Osteoporos Int. 2017 Dec 1. pii: 10.1007/s00198-017-4325.
    PubMed     Text format     Abstract available


    November 2017
  307. BREDEMEIER M
    Comments on Mignot et al.: bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Osteoporos Int. 2017 Nov 27. pii: 10.1007/s00198-017-4263.
    PubMed     Text format    


  308. PACCOU J, Cortet B
    Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk. Response to comments by Bredemeier.
    Osteoporos Int. 2017 Nov 27. pii: 10.1007/s00198-017-4320.
    PubMed     Text format    


  309. NOGUES X, Nolla JM, Casado E, Jodar E, et al
    Spanish consensus on treat to target for osteoporosis.
    Osteoporos Int. 2017 Nov 24. pii: 10.1007/s00198-017-4310.
    PubMed     Text format     Abstract available


  310. VRANKEN L, Wyers CE, Van der Velde RY, Janzing HM, et al
    Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service.
    Osteoporos Int. 2017 Nov 23. pii: 10.1007/s00198-017-4290.
    PubMed     Text format     Abstract available


  311. YANG L, Parimi N, Orwoll ES, Black DM, et al
    Association of incident hip fracture with the estimated femoral strength by finite element analysis of DXA scans in the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2017 Nov 22. doi: 10.1007/s00198-017-4319.
    PubMed     Text format     Abstract available


  312. WATANABE R, Tai N, Hirano J, Ban Y, et al
    Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease.
    Osteoporos Int. 2017 Nov 22. doi: 10.1007/s00198-017-4314.
    PubMed     Text format     Abstract available


  313. GOH SSL, Lai PSM, Tan ATB, Ponnampalavanar S, et al
    Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Osteoporos Int. 2017 Nov 20. doi: 10.1007/s00198-017-4305.
    PubMed     Text format     Abstract available


  314. MAKITIE RE, Niinimaki R, Kakko S, Honkanen T, et al
    Defective WNT signaling associates with bone marrow fibrosis-a cross-sectional cohort study in a family with WNT1 osteoporosis.
    Osteoporos Int. 2017 Nov 16. doi: 10.1007/s00198-017-4309.
    PubMed     Text format     Abstract available


  315. JOHANSSON L, Sundh D, Nilsson M, Mellstrom D, et al
    Vertebral fractures and their association with health-related quality of life, back pain and physical function in older women.
    Osteoporos Int. 2017 Nov 15. doi: 10.1007/s00198-017-4296.
    PubMed     Text format     Abstract available


  316. SCHONENBERG D, Guggenberger R, Frey D, Pape HC, et al
    CT-based evaluation of volumetric bone density in fragility fractures of the pelvis-a matched case-control analysis.
    Osteoporos Int. 2017 Nov 13. doi: 10.1007/s00198-017-4307.
    PubMed     Text format     Abstract available


  317. CHENBHANICH J, Thongprayoon C, Atsawarungruangkit A, Phupitakphol T, et al
    Osteoporosis and bone mineral density in patients with Wilson's disease: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Nov 6. doi: 10.1007/s00198-017-4295.
    PubMed     Text format     Abstract available


  318. MODI A, Sen S, Adachi JD, Adami S, et al
    The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study.
    Osteoporos Int. 2017 Nov 6. doi: 10.1007/s00198-017-4271.
    PubMed     Text format     Abstract available


  319. AL-SARI UA, Tobias JH, Clark EM
    Self-reported everyday physical activities in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4287.
    PubMed     Text format     Abstract available


  320. KAZE AD, Rosen HN, Paik JM
    A meta-analysis of the association between body mass index and risk of vertebral fracture.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4294.
    PubMed     Text format     Abstract available


    October 2017
  321. SCHOUSBOE JT, Vo TN, Langsetmo L, Taylor BC, et al
    Predictors of change of trabecular bone score (TBS) in older men: results from the Osteoporotic Fractures in Men (MrOS) Study.
    Osteoporos Int. 2017 Oct 31. doi: 10.1007/s00198-017-4273.
    PubMed     Text format     Abstract available


  322. GREENSPAN SL, Vujevich K, Britton C, Herradura A, et al
    Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.
    Osteoporos Int. 2017 Oct 30. doi: 10.1007/s00198-017-4286.
    PubMed     Text format     Abstract available


  323. RUPPERT K, Cauley J, Lian Y, Zgibor JC, et al
    The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study.
    Osteoporos Int. 2017 Oct 27. doi: 10.1007/s00198-017-4276.
    PubMed     Text format     Abstract available


  324. SPIERINGS J, Bours S, Peeters HRM
    A case of regional migratory osteoporosis.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4240.
    PubMed     Text format     Abstract available


  325. RATHBUN AM, Magaziner J, Shardell MD, Yerges-Armstrong LM, et al
    Older men who sustain a hip fracture experience greater declines in bone mineral density at the contralateral hip than non-fractured comparators.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4280.
    PubMed     Text format     Abstract available


  326. SU Y, Leung J, Kwok T
    The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4277.
    PubMed     Text format     Abstract available


  327. DUNN P, Webb D, Olenginski TP
    Geisinger high-risk osteoporosis clinic (HiROC): 2013-2015 FLS performance analysis.
    Osteoporos Int. 2017 Oct 23. doi: 10.1007/s00198-017-4270.
    PubMed     Text format     Abstract available


  328. DONG XL, Yu WX, Li CM, He S, et al
    Danshen (Salvia miltiorrhiza) protects ovariectomized rats fed with high-saturated fat-sucrose diet from bone loss.
    Osteoporos Int. 2017 Oct 23. doi: 10.1007/s00198-017-4254.
    PubMed     Text format     Abstract available


  329. AHN SH, Seo DH, Kim SH, Nam MS, et al
    The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011.
    Osteoporos Int. 2017 Oct 19. doi: 10.1007/s00198-017-4257.
    PubMed     Text format     Abstract available


  330. KASTNER M, Perrier L, Munce SEP, Adhihetty CC, et al
    Complex interventions can increase osteoporosis investigations and treatment: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Oct 18. doi: 10.1007/s00198-017-4248.
    PubMed     Text format     Abstract available


  331. MALMGREN L, McGuigan F, Christensson A, Akesson KE, et al
    Reduced kidney function is associated with BMD, bone loss and markers of mineral homeostasis in older women: a 10-year longitudinal study.
    Osteoporos Int. 2017 Oct 16. doi: 10.1007/s00198-017-4221.
    PubMed     Text format     Abstract available


  332. LIN SM, Yang SH, Liang CC, Huang HK, et al
    Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Osteoporos Int. 2017 Oct 14. doi: 10.1007/s00198-017-4262.
    PubMed     Text format     Abstract available


  333. BINKLEY N, Besuyen R, Fuerst T, Skillern L, et al
    Is drug-induced bone loss acceptable in premenopausal women? A practical fracture risk modeling exercise.
    Osteoporos Int. 2017 Oct 10. doi: 10.1007/s00198-017-4258.
    PubMed     Text format     Abstract available


  334. MALLUCHE HH, Monier-Faugere MC, Blomquist G, Davenport DL, et al
    Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.
    Osteoporos Int. 2017 Oct 9. doi: 10.1007/s00198-017-4228.
    PubMed     Text format     Abstract available


  335. TSENG OL, Dawes MG, Spinelli JJ, Gotay CC, et al
    Utilization of bone mineral density testing among breast cancer survivors in British Columbia, Canada.
    Osteoporos Int. 2017 Oct 9. doi: 10.1007/s00198-017-4218.
    PubMed     Text format     Abstract available


  336. RODRIGUEZ AJ, Scott D, Ebeling PR
    Comments on Li et al.: Meta-analysis of hypertension and osteoporotic fracture risk in women and men.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4246.
    PubMed     Text format    


  337. LI C, Wang Q
    Meta-analysis of hypertension and osteoporotic fracture risk in women and men: response to comments by Rodriguez et al.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4245.
    PubMed     Text format    


  338. YANG S, Leslie WD, Luo Y, Goertzen AL, et al
    Automated DXA-based finite element analysis for hip fracture risk stratification: a cross-sectional study.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4232.
    PubMed     Text format     Abstract available


  339. ZANCHETTA MB, Boailchuk J, Massari F, Silveira F, et al
    Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study.
    Osteoporos Int. 2017 Oct 3. doi: 10.1007/s00198-017-4242.
    PubMed     Text format     Abstract available


  340. MACK DE, Wilson PM, Santos E, Brooks K, et al
    Standards of reporting: the use of CONSORT PRO and CERT in individuals living with osteoporosis.
    Osteoporos Int. 2017 Oct 2. doi: 10.1007/s00198-017-4249.
    PubMed     Text format     Abstract available


  341. DALLA VIA J, Daly RM, Fraser SF
    The effect of exercise on bone mineral density in adult cancer survivors: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Oct 2. doi: 10.1007/s00198-017-4237.
    PubMed     Text format     Abstract available


    September 2017
  342. FREDERIKSEN A, Abrahamsen B, Johansen PB, Sorensen HA, et al
    Danish, national cross-sectional observational study on the prevalence of prior major osteoporotic fractures in adults presenting with hip fracture-limitations and scope for fracture liaison services in prevention of hip fracture.
    Osteoporos Int. 2017 Sep 30. doi: 10.1007/s00198-017-4247.
    PubMed     Text format     Abstract available


  343. KYVERNITAKIS I, Reuter TC, Hellmeyer L, Hars O, et al
    Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.
    Osteoporos Int. 2017 Sep 30. doi: 10.1007/s00198-017-4239.
    PubMed     Text format     Abstract available


  344. HOLLOWAY KL, Mohebbi M, Betson AG, Hans D, et al
    Prediction of major osteoporotic and hip fractures in Australian men using FRAX scores adjusted with trabecular bone score.
    Osteoporos Int. 2017 Sep 23. doi: 10.1007/s00198-017-4226.
    PubMed     Text format     Abstract available


  345. WRIGHT NC, Saag KG, Dawson-Hughes B, Khosla S, et al
    The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation.
    Osteoporos Int. 2017 Sep 21. doi: 10.1007/s00198-017-4207.
    PubMed     Text format     Abstract available


  346. LARSEN AU, Grimnes G, Jorde R
    The effect of high-dose vitamin D3 supplementation on bone mineral density in subjects with prediabetes.
    Osteoporos Int. 2017 Sep 18. doi: 10.1007/s00198-017-4222.
    PubMed     Text format     Abstract available


  347. BRIOT K, Geusens P, Em Bultink I, Lems WF, et al
    Inflammatory diseases and bone fragility.
    Osteoporos Int. 2017 Sep 15. doi: 10.1007/s00198-017-4189.
    PubMed     Text format     Abstract available


  348. ANSARI H, Beaton DE, Sujic R, Rotondi NK, et al
    Equal treatment: no evidence of gender inequity in osteoporosis management in a coordinator-based fragility fracture screening program.
    Osteoporos Int. 2017 Sep 10. doi: 10.1007/s00198-017-4206.
    PubMed     Text format     Abstract available


  349. NGUYEN VT, Edmonds SW, Lou Y, Roblin DW, et al
    Validity, reliability, and responsiveness to change of the "Osteoporosis and You" knowledge scale.
    Osteoporos Int. 2017 Sep 7. doi: 10.1007/s00198-017-4204.
    PubMed     Text format     Abstract available


  350. CALLEGARI ET, Garland SM, Gorelik A, Wark JD, et al
    Erratum to: Determinants of bone mineral density in young Australian women; results from the Safe-D study.
    Osteoporos Int. 2017 Sep 6. doi: 10.1007/s00198-017-4210.
    PubMed     Text format    


  351. LAROCHE M, Talibart M, Cormier C, Roux C, et al
    Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature.
    Osteoporos Int. 2017 Sep 6. doi: 10.1007/s00198-017-4165.
    PubMed     Text format     Abstract available


  352. ROTHMANN MJ, Moller S, Holmberg T, Hojberg M, et al
    Non-participation in systematic screening for osteoporosis-the ROSE trial.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4205.
    PubMed     Text format     Abstract available


  353. MIGNOT MA, Taisne N, Legroux I, Cortet B, et al
    Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4215.
    PubMed     Text format     Abstract available


  354. KAEWBOONCHOO O, Sung FC, Lin CL, Hsu HC, et al
    Hip fracture risk in patients with burn injury: a retrospective cohort study in Taiwan.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4209.
    PubMed     Text format     Abstract available


  355. CELLI M, D'Eufemia P, Persiani P, Turchetti A, et al
    Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG).
    Osteoporos Int. 2017 Sep 2. doi: 10.1007/s00198-017-4214.
    PubMed     Text format     Abstract available


    August 2017
  356. LITWIC AE, Compston JE, Wyman A, Siris ES, et al
    Self-perception of fracture risk: what can it tell us?
    Osteoporos Int. 2017 Aug 31. doi: 10.1007/s00198-017-4200.
    PubMed     Text format     Abstract available


  357. ROUX C, Baron G, Briot K, Roux B, et al
    Management of oral bisphosphonates treatment by rheumatologists and determinants of therapeutic changes: a case-vignette-based study.
    Osteoporos Int. 2017 Aug 29. doi: 10.1007/s00198-017-4188.
    PubMed     Text format     Abstract available


  358. MALGO F, Hamdy NAT, Ticheler CHJM, Smit F, et al
    Value and potential limitations of vertebral fracture assessment (VFA) compared to conventional spine radiography: experience from a fracture liaison service (FLS) and a meta-analysis.
    Osteoporos Int. 2017 Aug 25. doi: 10.1007/s00198-017-4137.
    PubMed     Text format     Abstract available


  359. MIYAKOSHI N, Kudo D, Hongo M, Kasukawa Y, et al
    Comparison of spinal alignment, muscular strength, and quality of life between women with postmenopausal osteoporosis and healthy volunteers.
    Osteoporos Int. 2017 Aug 7. doi: 10.1007/s00198-017-4184.
    PubMed     Text format     Abstract available


  360. KANIS JA, Cooper C, Rizzoli R, Abrahamsen B, et al
    Erratum to: Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
    Osteoporos Int. 2017 Aug 7. doi: 10.1007/s00198-017-4161.
    PubMed     Text format    


  361. JOHANSSON H, Azizieh F, Al Ali N, Alessa T, et al
    FRAX- vs. T-score-based intervention thresholds for osteoporosis.
    Osteoporos Int. 2017 Aug 7. doi: 10.1007/s00198-017-4160.
    PubMed     Text format     Abstract available


  362. SAITO T, Sterbenz JM, Malay S, Zhong L, et al
    Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis.
    Osteoporos Int. 2017 Aug 2. doi: 10.1007/s00198-017-4175.
    PubMed     Text format     Abstract available


    July 2017
  363. CHOU L, Shamdasani P, Briggs AM, Cicuttini FM, et al
    Systematic scoping review of patients' perceived needs of health services for osteoporosis.
    Osteoporos Int. 2017 Jul 31. doi: 10.1007/s00198-017-4167.
    PubMed     Text format     Abstract available


  364. WILLIAMS ST, Lawrence PT, Miller KL, Crook JL, et al
    A comparison of electronic and manual fracture risk assessment tools in screening elderly male US veterans at risk for osteoporosis.
    Osteoporos Int. 2017 Jul 30. doi: 10.1007/s00198-017-4172.
    PubMed     Text format     Abstract available


  365. KOH JH, Myong JP, Yoo J, Lim YW, et al
    Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Osteoporos Int. 2017 Jul 27. doi: 10.1007/s00198-017-4169.
    PubMed     Text format     Abstract available


  366. KAMPE AJ, Costantini A, Makitie RE, Jantti N, et al
    PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4150.
    PubMed     Text format     Abstract available


  367. MCCLUNG MR, Lippuner K, Brandi ML, Zanchetta JR, et al
    Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4140.
    PubMed     Text format     Abstract available


  368. VAN DER VELDE RY, Bours SPG, Wyers CE, Lems WF, et al
    Effect of implementation of guidelines on assessment and diagnosis of vertebral fractures in patients older than 50 years with a recent non-vertebral fracture.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4147.
    PubMed     Text format     Abstract available


  369. ZENG Y, Zhang L, Zhu W, He H, et al
    Network based subcellular proteomics in monocyte membrane revealed novel candidate genes involved in osteoporosis.
    Osteoporos Int. 2017 Jul 24. doi: 10.1007/s00198-017-4146.
    PubMed     Text format     Abstract available


  370. POP LM, Lingvay I, Yuan Q, Li X, et al
    Impact of pioglitazone on bone mineral density and bone marrow fat content.
    Osteoporos Int. 2017 Jul 22. doi: 10.1007/s00198-017-4164.
    PubMed     Text format     Abstract available


  371. NASIRI SARVI M, Luo Y
    Sideways fall-induced impact force and its effect on hip fracture risk: a review.
    Osteoporos Int. 2017 Jul 20. doi: 10.1007/s00198-017-4138.
    PubMed     Text format     Abstract available


  372. REYES C, Tebe C, Martinez-Laguna D, Ali MS, et al
    One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study.
    Osteoporos Int. 2017 Jul 16. doi: 10.1007/s00198-017-4144.
    PubMed     Text format     Abstract available


  373. DRIESSEN JHM, Knapen LM, Geusens PPMM, van den Bergh JPW, et al
    Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?
    Osteoporos Int. 2017 Jul 13. doi: 10.1007/s00198-017-4120.
    PubMed     Text format    


  374. KOSTEV K, Dombrowski S
    Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: response to Driessen et al.
    Osteoporos Int. 2017 Jul 13. doi: 10.1007/s00198-017-4139.
    PubMed     Text format    


  375. COSMAN F
    Spine fracture prevalence in a nationally representative sample of US women and men aged >/=40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014---supplementary presentation.
    Osteoporos Int. 2017 Jul 10. doi: 10.1007/s00198-017-3999.
    PubMed     Text format     Abstract available


  376. SHI L, Gao F, Sun W, Wang B, et al
    Short-term effects of extracorporeal shock wave therapy on bone mineral density in postmenopausal osteoporotic patients.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4136.
    PubMed     Text format     Abstract available


  377. NGUYEN VH
    Osteoporosis exercise knowledge and education in medicine and nursing.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4119.
    PubMed     Text format    


  378. GIANGREGORIO L, Clark R, McArthur C, Papaioannou A, et al
    Osteoporosis exercise knowledge and education in medicine and nursing: response to comments by Nguyen.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4121.
    PubMed     Text format    


  379. XUE F, Goli V, Petraro P, McMullan T, et al
    Marginal structural model to evaluate the association between cumulative osteoporosis medication and infection using claims data.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4129.
    PubMed     Text format     Abstract available


  380. CARFI A, Liperoti R, Fusco D, Giovannini S, et al
    Bone mineral density in adults with Down syndrome.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4133.
    PubMed     Text format     Abstract available


  381. HANUSCH BC, Tuck SP, McNally RJQ, Wu JJ, et al
    Does regional loss of bone density explain low trauma distal forearm fractures in men (the Mr F study)?
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4122.
    PubMed     Text format     Abstract available



  382. WORLD CONGRESS ON OSTEOPOROSIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  383. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Author Index.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  384. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): ESCEO Symposia Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  385. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Meet-the-Experts Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  386. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Plenary Lectures Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  387. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Honorary Lecture Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  388. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Oral Communication Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  389. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Satellite Symposia Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  390. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Educational Lecture Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  391. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Non-sponsored Symposia Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  392. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Committee of National Societies Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  393. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): World Health Organization (WHO) Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  394. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Poster Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    


    June 2017
  395. MENDIS AS, Ganda K, Seibel MJ
    Barriers to secondary fracture prevention in primary care.
    Osteoporos Int. 2017 Jun 29. doi: 10.1007/s00198-017-4131.
    PubMed     Text format     Abstract available


  396. CALLEGARI ET, Garland SM, Gorelik A, Wark JD, et al
    Determinants of bone mineral density in young Australian women; results from the Safe-D study.
    Osteoporos Int. 2017 Jun 28. doi: 10.1007/s00198-017-4100.
    PubMed     Text format     Abstract available


  397. AMORIM T, Koutedakis Y, Nevill A, Wyon M, et al
    Bone mineral density in vocational and professional ballet dancers.
    Osteoporos Int. 2017 Jun 27. doi: 10.1007/s00198-017-4130.
    PubMed     Text format     Abstract available


  398. FISCHER S, Kapinos KA, Mulcahy A, Pinto L, et al
    Estimating the long-term functional burden of osteoporosis-related fractures.
    Osteoporos Int. 2017 Jun 24. doi: 10.1007/s00198-017-4110.
    PubMed     Text format     Abstract available


  399. LOGAN S, Thu WPP, Lay WK, Wang LY, et al
    Chronic joint pain and handgrip strength correlates with osteoporosis in mid-life women: a Singaporean cohort.
    Osteoporos Int. 2017 Jun 24. doi: 10.1007/s00198-017-4095.
    PubMed     Text format     Abstract available


  400. KURODA T, Ohta H, Onoe Y, Tsugawa N, et al
    Intake of omega-3 fatty acids contributes to bone mineral density at the hip in a younger Japanese female population.
    Osteoporos Int. 2017 Jun 23. doi: 10.1007/s00198-017-4128.
    PubMed     Text format     Abstract available


  401. MODI A, Sen S, Adachi JD, Adami S, et al
    Association of gastrointestinal events with quality of life and treatment satisfaction in osteoporosis patients: results from the Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC OS).
    Osteoporos Int. 2017 Jun 22. doi: 10.1007/s00198-017-4116.
    PubMed     Text format     Abstract available


  402. OSHAGBEMI OA, Driessen JHM, Pieffers A, Wouters EFM, et al
    Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis.
    Osteoporos Int. 2017 Jun 21. doi: 10.1007/s00198-017-4115.
    PubMed     Text format     Abstract available


  403. LV F, Ma M, Liu W, Xu X, et al
    A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid.
    Osteoporos Int. 2017 Jun 16. doi: 10.1007/s00198-017-4094.
    PubMed     Text format     Abstract available


  404. WEYCKER D, Edelsberg J, Barron R, Atwood M, et al
    Predictors of near-term fracture in osteoporotic women aged >/=65 years, based on data from the study of osteoporotic fractures.
    Osteoporos Int. 2017 Jun 7. doi: 10.1007/s00198-017-4103.
    PubMed     Text format     Abstract available


  405. WRIGHT NC, Foster PJ, Mudano AS, Melnick JA, et al
    Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.
    Osteoporos Int. 2017 Jun 7. doi: 10.1007/s00198-017-4105.
    PubMed     Text format    


  406. LESLIE WD, Majumdar SR, Morin SN, Lix LM, et al
    FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
    Osteoporos Int. 2017 Jun 7. doi: 10.1007/s00198-017-4091.
    PubMed     Text format     Abstract available


  407. SVENSSON HK, Olsson L-, Hansson T, Karlsson J, et al
    The effects of person-centered or other supportive interventions in older women with osteoporotic vertebral compression fractures-a systematic review of the literature.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4099.
    PubMed     Text format     Abstract available


  408. BLANCO E, Burrows R, Reyes M, Lozoff B, et al
    Breastfeeding as the sole source of milk for 6 months and adolescent bone mineral density.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4106.
    PubMed     Text format     Abstract available


  409. LEHMANN T, Aeberli D
    Possible protective effect of switching from denosumab to zoledronic acid on vertebral fractures.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4108.
    PubMed     Text format    


  410. SHIEK AHMAD B, Petty SJ, Gorelik A, O'Brien TJ, et al
    Bone loss with antiepileptic drug therapy: a twin and sibling study.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4098.
    PubMed     Text format     Abstract available


  411. COULSON J, Bagley L, Barnouin Y, Bradburn S, et al
    Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.
    Osteoporos Int. 2017 Jun 5. doi: 10.1007/s00198-017-4104.
    PubMed     Text format     Abstract available


  412. GIFRE L, Ruiz-Gaspa S, Carrasco JL, Portell E, et al
    Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy.
    Osteoporos Int. 2017 Jun 4. doi: 10.1007/s00198-017-4090.
    PubMed     Text format     Abstract available


  413. SHAH VN, Harrall KK, Shah CS, Gallo TL, et al
    Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature.
    Osteoporos Int. 2017 Jun 3. doi: 10.1007/s00198-017-4097.
    PubMed     Text format     Abstract available


  414. SAHNI S, Soedamah-Muthu SS, Weaver CM
    Higher milk intake increases fracture risk: confounding or true association?
    Osteoporos Int. 2017 Jun 1. doi: 10.1007/s00198-017-4088.
    PubMed     Text format    


    May 2017
  415. CUI L, Chen L, Xia W, Jiang Y, et al
    Vertebral fracture in postmenopausal Chinese women: a population-based study.
    Osteoporos Int. 2017 May 30. doi: 10.1007/s00198-017-4085.
    PubMed     Text format     Abstract available


  416. WRIGHT NC, Foster PJ, Mudano AS, Melnick JA, et al
    Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.
    Osteoporos Int. 2017 May 24. doi: 10.1007/s00198-017-4073.
    PubMed     Text format     Abstract available


  417. UEBELHART B, Rizzoli R, Ferrari SL
    Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonates.
    Osteoporos Int. 2017 May 24. doi: 10.1007/s00198-017-4080.
    PubMed     Text format     Abstract available


  418. KESHISHIAN A, Boytsov N, Burge R, Krohn K, et al
    Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population.
    Osteoporos Int. 2017 May 23. doi: 10.1007/s00198-017-4072.
    PubMed     Text format     Abstract available


  419. PEREZ-SAEZ MJ, Herrera S, Prieto-Alhambra D, Vilaplana L, et al
    Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation.
    Osteoporos Int. 2017 May 11. doi: 10.1007/s00198-017-4065.
    PubMed     Text format     Abstract available


  420. LIN YC, Huang TS, Wu JS, Cheung YC, et al
    Are bilateral decubitus views necessary in assessing for vertebral compression fractures using DXA vertebral fracture assessment?
    Osteoporos Int. 2017 May 9. doi: 10.1007/s00198-017-4040.
    PubMed     Text format     Abstract available


  421. BOGL HP, Aspenberg P, Schilcher J
    Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
    Osteoporos Int. 2017 May 4. doi: 10.1007/s00198-017-4058.
    PubMed     Text format     Abstract available


  422. MALGO F, Hamdy NAT, Papapoulos SE, Appelman-Dijkstra NM, et al
    Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site.
    Osteoporos Int. 2017 May 2. doi: 10.1007/s00198-017-4054.
    PubMed     Text format     Abstract available


  423. LAIRD E, Molloy AM, McNulty H, Ward M, et al
    Greater yogurt consumption is associated with increased bone mineral density and physical function in older adults.
    Osteoporos Int. 2017 May 1. doi: 10.1007/s00198-017-4049.
    PubMed     Text format     Abstract available


  424. LEE JH, Kim JH, Hong AR, Kim SW, et al
    Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism.
    Osteoporos Int. 2017;28:1667-1674.
    PubMed     Text format     Abstract available


  425. ZHOU L, Song J, Yang S, Meng S, et al
    Bone mass loss is associated with systolic blood pressure in postmenopausal women with type 2 diabetes in Tibet: a retrospective cross-sectional study.
    Osteoporos Int. 2017;28:1693-1698.
    PubMed     Text format     Abstract available


  426. MCCLUNG MR, Wagman RB, Miller PD, Wang A, et al
    Observations following discontinuation of long-term denosumab therapy.
    Osteoporos Int. 2017;28:1723-1732.
    PubMed     Text format     Abstract available


    April 2017
  427. KANIS JA, Cooper C, Rizzoli R, Abrahamsen B, et al
    Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4009.
    PubMed     Text format     Abstract available


  428. HASEGAWA T, Kawakita A, Ueda N, Funahara R, et al
    A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRO
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4063.
    PubMed     Text format     Abstract available


  429. MCCLOSKEY EV
    Identification of vertebral fractures: a moderately severe solution?
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4042.
    PubMed     Text format    


  430. LI C, Zeng Y, Tao L, Liu S, et al
    Meta-analysis of hypertension and osteoporotic fracture risk in women and men.
    Osteoporos Int. 2017 Apr 26. doi: 10.1007/s00198-017-4050.
    PubMed     Text format     Abstract available


  431. CLARK EM, Cummings SR, Schousboe JT
    Spinal radiographs in those with back pain-when are they appropriate to diagnose vertebral fractures?
    Osteoporos Int. 2017 Apr 25. doi: 10.1007/s00198-017-4052.
    PubMed     Text format     Abstract available


  432. GUAN Y, Lv F, Meng Y, Ma D, et al
    Association between bone mineral density, muscle strength, and vitamin D status in patients with myasthenia gravis: a cross-sectional study.
    Osteoporos Int. 2017 Apr 24. doi: 10.1007/s00198-017-4041.
    PubMed     Text format     Abstract available


  433. MOBERG L, Nilsson PM, Samsioe G, Sallsten G, et al
    Increased blood cadmium levels were not associated with increased fracture risk but with increased total mortality in women: the Malmo Diet and Cancer Study.
    Osteoporos Int. 2017 Apr 21. doi: 10.1007/s00198-017-4047.
    PubMed     Text format     Abstract available


  434. DOMBROWSKI S, Jacob L, Hadji P, Kostev K, et al
    Oral contraceptive use and fracture risk-a retrospective study of 12,970 women in the UK.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4036.
    PubMed     Text format     Abstract available


  435. SATO H, Kondo N, Nakatsue T, Wada Y, et al
    High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4038.
    PubMed     Text format     Abstract available


  436. YAN J, Liu HJ, Li H, Chen L, et al
    Circulating periostin levels increase in association with bone density loss and healing progression during the early phase of hip fracture in Chinese older women.
    Osteoporos Int. 2017 Apr 5. doi: 10.1007/s00198-017-4034.
    PubMed     Text format     Abstract available


  437. RODRIGUEZ AJ, Scott D, Hodge A, English DR, et al
    Associations between hip bone mineral density, aortic calcification and cardiac workload in community-dwelling older Australians.
    Osteoporos Int. 2017 Apr 4. doi: 10.1007/s00198-017-4024.
    PubMed     Text format     Abstract available


    March 2017
  438. GALLI S, Stocchero M, Andersson M, Karlsson J, et al
    The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation.
    Osteoporos Int. 2017 Mar 27. doi: 10.1007/s00198-017-4004.
    PubMed     Text format     Abstract available


  439. WU J, Xu L, Lv Y, Dong L, et al
    Quantitative analysis of efficacy and associated factors of calcium intake on bone mineral density in postmenopausal women.
    Osteoporos Int. 2017 Mar 23. doi: 10.1007/s00198-017-3993.
    PubMed     Text format     Abstract available


  440. CHEN YY, Feng JY, Ting WY, Yen YF, et al
    Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area.
    Osteoporos Int. 2017 Mar 22. doi: 10.1007/s00198-017-3939.
    PubMed     Text format     Abstract available


  441. MORIWAKI K, Mouri M, Hagino H
    Erratum to: Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.
    Osteoporos Int. 2017 Mar 21. doi: 10.1007/s00198-017-4006.
    PubMed     Text format    


  442. LAINE CM, Landin-Wilhelmsen K
    Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up.
    Osteoporos Int. 2017 Mar 21. doi: 10.1007/s00198-017-3981.
    PubMed     Text format     Abstract available


  443. THOMPSON MJ, Aitken DA, Otahal P, Cicolini J, et al
    The relationship between cumulative lifetime ultraviolet radiation exposure, bone mineral density, falls risk and fractures in older adults.
    Osteoporos Int. 2017 Mar 20. doi: 10.1007/s00198-017-4001.
    PubMed     Text format     Abstract available


  444. LOOKER AC, Sarafrazi Isfahani N, Fan B, Shepherd JA, et al
    Trends in osteoporosis and low bone mass in older US adults, 2005-2006 through 2013-2014.
    Osteoporos Int. 2017 Mar 18. doi: 10.1007/s00198-017-3996.
    PubMed     Text format     Abstract available


  445. MOHD-TAHIR NA, Li SC
    Economic burden of osteoporosis-related hip fracture in Asia: a systematic review.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3985.
    PubMed     Text format     Abstract available


  446. ASADIPOOYA K, Graves L, Greene LW
    Transient osteoporosis of the hip: review of the literature.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3952.
    PubMed     Text format     Abstract available


  447. POPP AW, Senn R, Curkovic I, Senn C, et al
    Factors associated with acute-phase response of bisphosphonate-naive or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate.
    Osteoporos Int. 2017 Mar 15. doi: 10.1007/s00198-017-3992.
    PubMed     Text format     Abstract available


  448. CHANG HK, Chang DG, Myong JP, Kim JH, et al
    Bone mineral density among Korean females aged 20-50 years: influence of age at menarche (The Korea National Health and Nutrition Examination Survey 2008-2011).
    Osteoporos Int. 2017 Mar 14. doi: 10.1007/s00198-017-3997.
    PubMed     Text format     Abstract available


  449. EASTELL R, Diez-Perez A
    Recommendations for the screening of adherence to oral bisphosphonates: reply to comments by Zhou and Sheng.
    Osteoporos Int. 2017 Mar 10. doi: 10.1007/s00198-017-3991.
    PubMed     Text format    


  450. ZHOU YH, Sheng ZF
    Comments on Diez-Perez et al.: Recommendations for the screening of adherence to oral bisphosphonates.
    Osteoporos Int. 2017 Mar 10. doi: 10.1007/s00198-017-3987.
    PubMed     Text format    


  451. MAJUMDAR SR, Lier DA, Hanley DA, Juby AG, et al
    Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
    Osteoporos Int. 2017 Mar 9. doi: 10.1007/s00198-017-3986.
    PubMed     Text format     Abstract available


  452. IMAI T, Tanaka S, Kawakami K, Miyazaki T, et al
    Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3966.
    PubMed     Text format     Abstract available


  453. MORIWAKI K, Mouri M, Hagino H
    Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3973.
    PubMed     Text format     Abstract available


  454. KERR C, Bottomley C, Shingler S, Giangregorio L, et al
    The importance of physical function to people with osteoporosis.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3911.
    PubMed     Text format     Abstract available


  455. HAN MH, Ryu JI, Kim CH, Kim JM, et al
    Influence of systemic bone mineral density on atlantoaxial subluxation in patients with rheumatoid arthritis.
    Osteoporos Int. 2017 Mar 2. doi: 10.1007/s00198-017-3972.
    PubMed     Text format     Abstract available


  456. WEI Y, Tian W, Zhang GL, Lv YW, et al
    Thoracolumbar kyphosis is associated with compressive vertebral fracture in postmenopausal women.
    Osteoporos Int. 2017 Mar 1. doi: 10.1007/s00198-017-3971.
    PubMed     Text format     Abstract available


    February 2017
  457. MERLE B, Chapurlat R, Vignot E, Thomas T, et al
    Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial.
    Osteoporos Int. 2017 Feb 28. doi: 10.1007/s00198-017-3953.
    PubMed     Text format     Abstract available


  458. TAMAKI J, Iki M, Sato Y, Kajita E, et al
    Total 25-hydroxyvitamin D levels predict fracture risk: results from the 15-year follow-up of the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Osteoporos Int. 2017 Feb 27. doi: 10.1007/s00198-017-3967.
    PubMed     Text format     Abstract available


  459. DU Y, Zhao LJ, Xu Q, Wu KH, et al
    Socioeconomic status and bone mineral density in adults by race/ethnicity and gender: the Louisiana osteoporosis study.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3951.
    PubMed     Text format     Abstract available


  460. MORFELD JC, Vennedey V, Muller D, Pieper D, et al
    Patient education in osteoporosis prevention: a systematic review focusing on methodological quality of randomised controlled trials.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3946.
    PubMed     Text format     Abstract available


  461. ROUX C, Briot K
    Imminent fracture risk.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3976.
    PubMed     Text format     Abstract available


  462. LEE SH, Hsu WT, Lai CC, Esmaily-Fard A, et al
    Erratum to: Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Feb 23. doi: 10.1007/s00198-017-3938.
    PubMed     Text format    


  463. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.
    Osteoporos Int. 2017 Feb 17. doi: 10.1007/s00198-017-3940.
    PubMed     Text format     Abstract available


  464. MARQUES ID, Araujo MJ, Graciolli FG, Reis LM, et al
    Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities.
    Osteoporos Int. 2017 Feb 16. doi: 10.1007/s00198-017-3956.
    PubMed     Text format     Abstract available


  465. COLARES NETO GP, Pereira RM, Alvarenga JC, Takayama L, et al
    Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets.
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3949.
    PubMed     Text format     Abstract available


  466. DEDE AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, et al
    Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3927.
    PubMed     Text format    


  467. MORTON A
    A role for thiazide diuretic therapy in preventing bone loss, fracture, and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3922.
    PubMed     Text format    


  468. LEE DY, Jee JH, Cho YY, Jang JY, et al
    Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis.
    Osteoporos Int. 2017 Feb 10. doi: 10.1007/s00198-016-3892.
    PubMed     Text format     Abstract available


  469. HARVEY NC, McCloskey EV, Mitchell PJ, Dawson-Hughes B, et al
    Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.
    Osteoporos Int. 2017 Feb 7. doi: 10.1007/s00198-016-3894.
    PubMed     Text format     Abstract available


  470. BALLANE G, Cauley JA, Luckey MM, El-Hajj Fuleihan G, et al
    Worldwide prevalence and incidence of osteoporotic vertebral fractures.
    Osteoporos Int. 2017 Feb 6. doi: 10.1007/s00198-017-3909.
    PubMed     Text format     Abstract available


  471. LESPESSAILLES E, Cortet B, Legrand E, Guggenbuhl P, et al
    Low-trauma fractures without osteoporosis.
    Osteoporos Int. 2017 Feb 4. doi: 10.1007/s00198-017-3921.
    PubMed     Text format     Abstract available


  472. MIKULA AL, Hetzel SJ, Binkley N, Anderson PA, et al
    Validity of height loss as a predictor for prevalent vertebral fractures, low bone mineral density, and vitamin D deficiency.
    Osteoporos Int. 2017 Feb 3. doi: 10.1007/s00198-017-3937.
    PubMed     Text format     Abstract available


    January 2017
  473. FU SJ, Sheng ZF
    Comments on Kamimura et al.: significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.
    Osteoporos Int. 2017 Jan 27. doi: 10.1007/s00198-016-3867.
    PubMed     Text format    


  474. KAMIMURA M, Nakamura Y, Ikegami S, Uchiyama S, et al
    Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments.
    Osteoporos Int. 2017 Jan 27. doi: 10.1007/s00198-017-3923.
    PubMed     Text format    


  475. OKUBO R, Sanada LS, Castania VA, Louzada MJ, et al
    Jumping exercise preserves bone mineral density and mechanical properties in osteopenic ovariectomized rats even following established osteopenia.
    Osteoporos Int. 2017 Jan 26. doi: 10.1007/s00198-017-3905.
    PubMed     Text format     Abstract available


  476. ALACREU E, Moratal D, Arana E
    Opportunistic screening for osteoporosis by routine CT in Southern Europe.
    Osteoporos Int. 2017 Jan 20. doi: 10.1007/s00198-016-3804.
    PubMed     Text format     Abstract available


  477. DIEZ-PEREZ A, Naylor KE, Abrahamsen B, Agnusdei D, et al
    International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates.
    Osteoporos Int. 2017 Jan 16. doi: 10.1007/s00198-017-3906.
    PubMed     Text format     Abstract available


  478. HONG AR, Kim JH, Lee KH, Kim TY, et al
    Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3899.
    PubMed     Text format     Abstract available


  479. LIM Y, Jo K, Ha HS, Yim HW, et al
    The prevalence of osteoporosis and the rate of bone loss in Korean adults: the Chungju metabolic disease cohort (CMC) study.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3893.
    PubMed     Text format     Abstract available


  480. LEE SH, Hsu WT, Lai CC, Amin EF, et al
    Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3881.
    PubMed     Text format     Abstract available


  481. HADJI P, Boekhoff J, Hahn M, Hellmeyer L, et al
    Pregnancy-associated osteoporosis: a case-control study.
    Osteoporos Int. 2017 Jan 10. doi: 10.1007/s00198-016-3897.
    PubMed     Text format     Abstract available


  482. MODI A, Sajjan S, Insinga R, Weaver J, et al
    Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years.
    Osteoporos Int. 2017 Jan 5. doi: 10.1007/s00198-016-3886.
    PubMed     Text format     Abstract available


    December 2016
  483. JOHANSSON H, Siggeirsdottir K, Harvey NC, Oden A, et al
    Imminent risk of fracture after fracture.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3868.
    PubMed     Text format     Abstract available


  484. BURGE RT, Disch DP, Gelwicks S, Zhang X, et al
    Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3888.
    PubMed     Text format     Abstract available


  485. FAHRLEITNER-PAMMER A, Wagner D, Krisper P, Amrein K, et al
    Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  486. MANA DL, Zanchetta MB, Zanchetta JR
    Retreatment with teriparatide: our experience in three patients with severe secondary osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  487. WRIGHT NC, Saag KG, Dawson-Hughes B, Khosla S, et al
    The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  488. FECHTENBAUM J, Kolta S, Briot K, Roux C, et al
    Vertebral fracture assessment by dual X-ray absorptiometry.
    Osteoporos Int. 2016.
    PubMed     Text format    


  489. RUD B, Hyldstrup L
    Vertebral fracture assessment by dual X-ray absorptiometry: reply to comments by Fechtenbaum et al.
    Osteoporos Int. 2016.
    PubMed     Text format    


  490. JUHASZ B, Gulyas K, Horvath A, Petho Z, et al
    Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  491. OTA M, Takahata M, Shimizu T, Kanehira Y, et al
    Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  492. CHEN GD, Ding D, Tian HY, Zhu YY, et al
    Adherence to the 2006 American Heart Association's Diet and Lifestyle Recommendations for cardiovascular disease risk reduction is associated with bone mineral density in older Chinese.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  493. ABDERHALDEN L, Weaver FM, Bethel M, Demirtas H, et al
    Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  494. CORREA CB, Camargos GV, Chatterjee M, Mesquita MF, et al
    Can the alendronate dosage be altered when combined with high-frequency loading in osteoporosis treatment?
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  495. CIRNIGLIARO CM, Myslinski MJ, La Fountaine MF, Kirshblum SC, et al
    Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  496. JAMAL SA, Reid LS, Hamilton CJ
    Statement of concern re: The effects of organic nitrates on osteoporosis: a systematic review.
    Osteoporos Int. 2016.
    PubMed     Text format    


  497. JAMAL SA, Goltzman D, Hanley DA, Papaioannou A, et al
    Retraction to: Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  498. ZHANG J, Hu X, Zhang J
    Associations between serum vitamin E concentration and bone mineral density in the US elderly population.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  499. DIVASTA AD, Feldman HA, Rubin CT, Gallagher JS, et al
    The ability of low-magnitude mechanical signals to normalize bone turnover in adolescents hospitalized for anorexia nervosa.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    November 2016
  500. MAWATARI T, Muraoka R, Iwamoto Y
    Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  501. NOGUCHI T, Ebina K, Hirao M, Morimoto T, et al
    Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  502. AN T, Hao J, Sun S, Li R, et al
    Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  503. JACOB L, Kostev K
    Impact of attention deficit hyperactivity disorder therapy on fracture risk in children treated in German pediatric practices.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  504. YOSHIMURA N, Muraki S, Oka H, Iidaka T, et al
    Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  505. SANCHEZ A, Blanco R
    Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  506. KIM H, Baek KH, Lee SY, Ahn SH, et al
    Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  507. KRUSE C, Eiken P, Vestergaard P
    Clinical fracture risk evaluated by hierarchical agglomerative clustering.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  508. ZHU W, Shen H, Zhang JG, Zhang L, et al
    Cytosolic proteome profiling of monocytes for male osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  509. RAY R, Clement ND, Aitken SA, McQueen MM, et al
    High mortality in younger patients with major osteoporotic fractures.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  510. GARCIA-HOYOS M, Garcia-Unzueta MT, de Luis D, Valero C, et al
    Diverging results of areal and volumetric bone mineral density in Down syndrome.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  511. MATHAVAN N, Tagil M, Isaksson H
    Do osteoporotic fractures constitute a greater recalcitrant challenge for skeletal regeneration? Investigating the efficacy of BMP-7 and zoledronate treatment of diaphyseal fractures in an open fracture osteoporotic rat model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  512. SHAH A, Prieto-Alhambra D, Hawley S, Delmestri A, et al
    Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available



  513. ABSTRACTS OF OSTEOPOROSIS CONFERENCE 2016.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  514. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Author index.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  515. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Plenary Lectures.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  516. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Oral Communications.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  517. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Poster Presentations.
    Osteoporos Int. 2016;27.
    PubMed     Text format    


    October 2016
  518. ZERBINI CA, Clark P, Mendez-Sanchez L, Pereira RM, et al
    Biologic therapies and bone loss in rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  519. BEATON DE, Vidmar M, Pitzul KB, Sujic R, et al
    Addition of a fracture risk assessment to a coordinator's role improved treatment rates within 6 months of screening in a fragility fracture screening program.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  520. BELHASSEN M, Confavreux CB, Cortet B, Lamezec L, et al
    Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  521. FINK HA, Litwack-Harrison S, Taylor BC, Bauer DC, et al
    Erratum to: Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the osteoporotic fractures in men (MrOS) study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  522. HARVEY NC, Biver E, Kaufman JM, Bauer J, et al
    The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Fo
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  523. TSENTIDIS C, Gourgiotis D, Kossiva L, Marmarinos A, et al
    Increased levels of Dickkopf-1 are indicative of Wnt/beta-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  524. IKI M, Fujita Y, Tamaki J, Kouda K, et al
    Incident fracture associated with increased risk of mortality even after adjusting for frailty status in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  525. HILIGSMANN M, Burlet N, Fardellone P, Al-Daghri N, et al
    Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  526. CHOI HS, Park JH, Kim SH, Shin S, et al
    Strong familial association of bone mineral density between parents and offspring: KNHANES 2008-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  527. YOSHIMURA M, Moriwaki K, Noto S, Takiguchi T, et al
    A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  528. FARMER S, Shanbhogue VV, Hansen S, Stahlberg CI, et al
    Bone mineral density and microarchitecture in patients with essential thrombocythemia and polycythemia vera.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  529. SU Y, Leung J, Hans D, Aubry-Rozier B, et al
    Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  530. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  531. PIRRO M, Mannarino MR, Bianconi V, De Vuono S, et al
    Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  532. WALLACE ER, Siscovick DS, Sitlani CM, Dublin S, et al
    Incident atrial fibrillation and the risk of fracture in the cardiovascular health study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  533. RODRIGUES IB, Armstrong JJ, Adachi JD, MacDermid JC, et al
    Facilitators and barriers to exercise adherence in patients with osteopenia and osteoporosis: a systematic review.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  534. KAMYCHEVA E, Goto T, Camargo CA Jr
    Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  535. MORIWAKI K, Noto S
    Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    September 2016
  536. ATTERITANO M, Di Mauro E, Canale V, Bruzzese AM, et al
    Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  537. CHEN J, Smerdely P
    Hypocalcaemia after denosumab in older people following fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  538. XU MH, Li X, Yuan FL
    Is it necessary to investigate rapamycin-modulated autophagy during the development of experimental osteoporosis in female rat?
    Osteoporos Int. 2016.
    PubMed     Text format    


  539. CHAKHTOURA M, Leslie WD, McClung M, Cheung AM, et al
    The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  540. KAMIMURA M, Nakamura Y, Ikegami S, Uchiyama S, et al
    Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  541. AVENELL A, Bolland MJ, Grey A, Reid IR, et al
    Further major uncorrected errors in National Osteoporosis Foundation meta-analyses of calcium and vitamin D supplementation in fracture prevention.
    Osteoporos Int. 2016.
    PubMed     Text format    


  542. SMALLWOOD AJ, Schapira MM, Fedders M, Neuner JM, et al
    A pilot randomized controlled trial of a decision aid with tailored fracture risk tool delivered via a patient portal.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  543. WU X, Wei D, Sun B, Wu XN, et al
    Poor medication adherence to bisphosphonates and high self-perception of aging in elderly female patients with osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  544. BALOGH R, Wood J, Dobranowski K, Lin E, et al
    Low-trauma fractures and bone mineral density testing in adults with and without intellectual and developmental disabilities: a population study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  545. NAKAMURA T, Fukunaga M, Nakano T, Kishimoto H, et al
    Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  546. PEREIRA L, Bliuc D, Stanford P, Eisman JA, et al
    More-than-minimal-trauma fractures are associated with low bone density: an 8-year prospective study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    July 2016
  547. SENAY A, Delisle J, Giroux M, Laflamme GY, et al
    The impact of a standardized order set for the management of non-hip fragility fractures in a Fracture Liaison Service.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    June 2016
  548. KARAYIANNIS PN, McAlinden MG
    Falling age-related incidence of hip fractures in women, but not men, in Northern Ireland: 2001-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    May 2016
  549. AXELSSON KF, Jacobsson R, Lund D, Lorentzon M, et al
    Effectiveness of a minimal resource fracture liaison service.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  550. SHIPMAN KE, Stammers J, Doyle A, Gittoes N, et al
    Delivering a quality-assured fracture liaison service in a UK teaching hospital-is it achievable?
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  551. MCCLUNG MR
    Cancel the denosumab holiday.
    Osteoporos Int. 2016;27:1677-82.
    PubMed     Text format    


  552. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Usefulness of daily teriparatide treatment in elderly patients over 80 years of age.
    Osteoporos Int. 2016;27:1869-74.
    PubMed     Text format     Abstract available


  553. PAUPITZ JA, Lima GL, Alvarenga JC, Oliveira RM, et al
    Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus.
    Osteoporos Int. 2016;27:1839-48.
    PubMed     Text format     Abstract available


    April 2016
  554. TSENTIDIS C, Gourgiotis D, Kossiva L, Doulgeraki A, et al
    Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Osteoporos Int. 2016;27:1631-43.
    PubMed     Text format     Abstract available


  555. HOFFMAN V, Xue F, Gardstein B, Skerry K, et al
    Assessment of off-label use of denosumab 60 mg injection during the early postmarketing period using health insurance claims data.
    Osteoporos Int. 2016;27:1653-8.
    PubMed     Text format     Abstract available


  556. JACQUOT J, Delion M, Gangloff S, Braux J, et al
    Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.
    Osteoporos Int. 2016;27:1401-12.
    PubMed     Text format     Abstract available


    March 2016
  557. BAE SJ, Lee SH, Ahn SH, Kim HM, et al
    The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  558. BUCKINX F, Reginster JY, Cavalier E, Petermans J, et al
    Determinants of vitamin D supplementation prescription in nursing homes: a survey among general practitioners.
    Osteoporos Int. 2016;27:881-6.
    PubMed     Text format     Abstract available


  559. MOSTI MP, Flemmen G, Hoff J, Stunes AK, et al
    Impaired skeletal health and neuromuscular function among amphetamine users in clinical treatment.
    Osteoporos Int. 2016;27:1003-10.
    PubMed     Text format     Abstract available


  560. ZHANG Y, Wang L, Song Y, Zhao X, et al
    Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.
    Osteoporos Int. 2016;27:1083-92.
    PubMed     Text format     Abstract available


  561. DAMIAN LO, Simon SP, Filipescu I, Bocsa C, et al
    Capillaroscopic findings in a case of Hajdu-Cheney syndrome.
    Osteoporos Int. 2016;27:1269-73.
    PubMed     Text format     Abstract available


  562. DUDLEY-JAVOROSKI S, Petrie MA, McHenry CL, Amelon RE, et al
    Bone architecture adaptations after spinal cord injury: impact of long-term vibration of a constrained lower limb.
    Osteoporos Int. 2016;27:1149-60.
    PubMed     Text format     Abstract available


    February 2016
  563. DRIESSEN JH, Hansen L, Eriksen SA, van Onzenoort HA, et al
    The epidemiology of fractures in Denmark in 2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  564. LAM FM, Bui M, Yang FZ, Pang MY, et al
    Chronic effects of stroke on hip bone density and tibial morphology: a longitudinal study.
    Osteoporos Int. 2016;27:591-603.
    PubMed     Text format     Abstract available


  565. VIAENE L, Behets GJ, Heye S, Claes K, et al
    Inflammation and the bone-vascular axis in end-stage renal disease.
    Osteoporos Int. 2016;27:489-97.
    PubMed     Text format     Abstract available


  566. HWANGBO Y, Kim JH, Kim SW, Park YJ, et al
    High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women.
    Osteoporos Int. 2016;27:457-62.
    PubMed     Text format     Abstract available


  567. KAWALILAK CE, Johnston JD, Cooper DM, Olszynski WP, et al
    Role of endocortical contouring methods on precision of HR-pQCT-derived cortical micro-architecture in postmenopausal women and young adults.
    Osteoporos Int. 2016;27:789-96.
    PubMed     Text format     Abstract available


  568. KHEIR V, Munier FL, Aubry-Rozier B, Schorderet DF, et al
    Potential blindness in children of patients with hereditary bone disease.
    Osteoporos Int. 2016;27:841-4.
    PubMed     Text format     Abstract available


  569. TAN J, Fu X, Sun CG, Liu C, et al
    A single CT-guided percutaneous intraosseous injection of thermosensitive simvastatin/poloxamer 407 hydrogel enhances vertebral bone formation in ovariectomized minipigs.
    Osteoporos Int. 2016;27:757-67.
    PubMed     Text format     Abstract available


    January 2016
  570. DREW S, Judge A, Cooper C, Javaid MK, et al
    Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  571. LEIB ES, Winzenrieth R
    Bone status in glucocorticoid-treated men and women.
    Osteoporos Int. 2016;27:39-48.
    PubMed     Text format     Abstract available


  572. MATUTE-LLORENTE A, Gonzalez-Aguero A, Gomez-Cabello A, Tous-Fajardo J, et al
    Effect of whole-body vibration training on bone mass in adolescents with and without Down syndrome: a randomized controlled trial.
    Osteoporos Int. 2016;27:181-91.
    PubMed     Text format     Abstract available


  573. EASTELL R, Dijk DJ, Small M, Greenwood A, et al
    Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial.
    Osteoporos Int. 2016;27:309-18.
    PubMed     Text format     Abstract available


    December 2015
  574. NAKAYAMA A, Major G, Holliday E, Attia J, et al
    Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  575. RUDANG R, Zoulakis M, Sundh D, Brisby H, et al
    Bone material strength is associated with areal BMD but not with prevalent fractures in older women.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    November 2015
  576. SENAY A, Delisle J, Raynauld JP, Morin SN, et al
    Agreement between physicians' and nurses' clinical decisions for the management of the fracture liaison service (4iFLS): the Lucky Bone program.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  577. BEALL DP, Feldman RG, Gordon ML, Gruber BL, et al
    Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  578. SUMIDA K, Ubara Y, Hoshino J, Mise K, et al
    Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    October 2015
  579. SELGA J, Nunez JH, Minguell J, Lalanza M, et al
    Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  580. RAMCHAND SK, Chiang CY, Zebaze RM, Seeman E, et al
    Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    August 2015
  581. EDWARDS BJ, Gradishar WJ, Smith ME, Pacheco JA, et al
    Elevated incidence of fractures in women with invasive breast cancer.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  582. HOLZMUELLER CG, Karp S, Zeldow D, Lee DB, et al
    Development of a cloud-based application for the Fracture Liaison Service model of care.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  583. YONG JH, Masucci L, Hoch JS, Sujic R, et al
    Cost-effectiveness of a fracture liaison service-a real-world evaluation after 6 years of service provision.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  584. LESLIE WD, Brennan-Olsen SL, Morin SN, Lix LM, et al
    Fracture prediction from repeat BMD measurements in clinical practice.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: